Document:

QuickLinks
 -- Click here to rapidly navigate through this document
 

 

 
 

Exhibit 10.21    
    

 
 
  RIGEL  PHARMACEUTICALS, INC.
  
    2000 EQUITY INCENTIVE PLAN
  
    ADOPTED JANUARY 27, 2000
  APPROVED BY STOCKHOLDERS MARCH 15, 2000
  AMENDED DECEMBER 13,
2002
  AMENDED AND RESTATED APRIL 24, 2003
  APPROVED BY STOCKHOLDERS JUNE 20, 2003
  AMENDED AND RESTATED APRIL 22, 2005
  APPROVED BY STOCKHOLDERS JUNE 2, 2005
  AMENDED AND RESTATED MARCH 10, 2006 AND
APRIL 18, 2006
  APPROVED BY STOCKHOLDERS MAY 30, 2006
  AMENDED JANUARY 31, 2007
  APPROVED BY STOCKHOLDERS MAY 31, 2007
  AMENDED FEBRUARY 21, 2008
  APPROVED BY STOCKHOLDERS MAY 29, 2008
  TERMINATION
DATE: APRIL 24, 2013    

1.     PURPOSES.

        (a)   The Plan is an amendment and restatement of, and is intended to supersede and replace, the Company's 1997 Stock Option
Plan. 

        (b)   The persons eligible to receive Stock Awards are the Employees, Directors and Consultants of the Company and its
Affiliates. 

        (c)   The purpose of the Plan is to provide a means by which eligible recipients of Stock Awards may be given an opportunity to
benefit from increases in value of the Common Stock through the granting of the following Stock Awards: (i) Incentive Stock Options, (ii) Nonstatutory Stock Options, (iii) stock
bonuses and (iv) rights to acquire restricted stock. 

        (d)   The Company, by means of the Plan, seeks to retain the services of the group of persons eligible to receive Stock Awards,
to secure and retain the services of new members of this group and to provide incentives for such persons to exert maximum efforts for the success of the Company and its Affiliates. 

        (e)   Any stock awards granted under the Rigel Pharmaceuticals, Inc. 2001 Non-Officer Equity Incentive Plan
(the "Non-Officer Plan") prior to April 24, 2003 shall be governed by the terms of the Non-Officer Plan as in effect immediately prior to April 24, 2003, as set
forth in Appendix A to this Plan. The Common Stock that was reserved for issuance under the Non-Officer Plan, including the Common Stock that may be issued pursuant to outstanding
stock awards granted under the Non-Officer Plan prior to April 24, 2003, shall be included in the aggregate share reserve for this Plan, as set forth in subsection 4(a). 

2.     DEFINITIONS.

        (a)   "Affiliate" means any parent corporation or subsidiary corporation of the Company, whether now or
hereafter existing, as those terms are defined in Sections 424(e) and (f), respectively, of the Code. 

        (b)   "Board" means the Board of Directors of the Company. 

        (c)   "Code" means the Internal Revenue Code of 1986, as amended. 

A-1

 

        (d)   "Committee" means a committee of one or more members of the Board appointed by the Board in
accordance with subsection 3(c). 

        (e)   "Common Stock" means the common stock of the Company. 

        (f)    "Company" means Rigel Pharmaceuticals, Inc., a Delaware corporation. 

        (g)   "Consultant" means any person, including an advisor, (i) engaged by the Company or an
Affiliate to render consulting or advisory services and who is compensated for such services or (ii) who is a member of the Board of Directors of an Affiliate. However, the term "Consultant"
shall not include either Directors who are not compensated by the Company for their services as Directors or Directors who are merely paid a director's fee by the Company for their services as
Directors. 

        (h)   "Continuous Service" means that the Participant's service with the Company or an Affiliate,
whether as an Employee, Director or Consultant, is not interrupted or terminated. The Participant's Continuous Service shall not be deemed to have terminated merely because of a change in the capacity
in which the Participant renders service to the Company or an Affiliate as an Employee, Consultant or Director or a change in the entity for which the Participant renders such service, provided that
there is no interruption or termination of the Participant's service. For example, a change in status without interruption from an Employee of the Company to a Consultant of an Affiliate or a Director
will not constitute an interruption of Continuous Service. The Board or the chief executive officer of the Company, in that party's sole discretion, may determine whether Continuous Service shall be
considered interrupted in the case of any leave of absence approved by that party, including sick leave, military leave or any other personal leave. 

        (i)    "Covered Employee" means the chief executive officer and the four (4) other highest
compensated officers of the Company for whom total compensation is required to be reported to stockholders under the Exchange Act, as determined for purposes of Section 162(m) of the Code. 

        (j)    "Director" means a member of the Board of Directors of the Company. 

        (k)   "Disability" means the permanent and total disability of a person within the meaning of
Section 22(e)(3) of the Code. 

        (l)    "Employee" means any person employed by the Company or an Affiliate. Mere service as a Director
or payment of a director's fee by the Company or an Affiliate shall not be sufficient to constitute "employment" by the Company or an Affiliate. 

        (m)  "Exchange Act" means the Securities Exchange Act of 1934, as amended. 

        (n)   "Fair Market Value" means, as of any date, the value of the Common Stock determined as follows: 

        (i)    If the Common Stock is listed on any established stock exchange or traded on the Nasdaq National Market or the Nasdaq
SmallCap Market, the Fair Market Value of a share of Common Stock shall be the closing sales price for such stock (or the closing bid, if no sales were reported) as quoted on such exchange or market
(or the exchange or market with the greatest volume of trading in the Common Stock) on the last market trading day prior to the day of determination, as reported in The Wall
Street Journal or such other source as the Board deems reliable. 

        (ii)   In the absence of such markets for the Common Stock, the Fair Market Value shall be determined in good faith by the
Board. 

        (o)   "Incentive Stock Option" means an Option intended to qualify as an incentive stock option within
the meaning of Section 422 of the Code and the regulations promulgated thereunder. 

        (p)   "Non-Employee Director" means a Director who either (i) is not a current
Employee or Officer of the Company or its parent or a subsidiary, does not receive compensation (directly or indirectly) from the Company or its parent or a subsidiary for services rendered as a
consultant or in any capacity 

A-2

 

other
than as a Director (except for an amount as to which disclosure would not be required under Item 404(a) of Regulation S-K promulgated pursuant to the Securities Act
("Regulation S-K")), does not possess an interest in any other transaction as to which disclosure would be required under Item 404(a) of Regulation S-K and
is not engaged in a business relationship as to which disclosure would be required under Item 404(b) of Regulation S-K; or (ii) is otherwise considered a
"non-employee director" for purposes of Rule 16b-3. 

        (q)   "Nonstatutory Stock Option" means an Option not intended to qualify as an Incentive Stock Option. 

        (r)   "Officer" means a person who is an officer of the Company within the meaning of Section 16
of the Exchange Act and the rules and regulations promulgated thereunder. 

        (s)   "Option" means an Incentive Stock Option or a Nonstatutory Stock Option granted pursuant to the
Plan. 

        (t)    "Option Agreement" means a written agreement between the Company and an Optionholder evidencing
the terms and conditions of an individual Option grant. Each Option Agreement shall be subject to the terms and conditions of the Plan. 

        (u)   "Optionholder" means a person to whom an Option is granted pursuant to the Plan or, if
applicable, such other person who holds an outstanding Option. 

        (v)   "Outside Director" means a Director who either (i) is not a current employee of the
Company or an "affiliated corporation" (within the meaning of Treasury Regulations promulgated under Section 162(m) of the Code), is not a former employee of the Company or an "affiliated
corporation" receiving compensation for prior services (other than benefits under a tax qualified pension plan), was not an officer of the Company or an "affiliated corporation" at any time and is not
currently receiving direct or indirect remuneration from the Company or an "affiliated corporation" for services in any capacity other than as a Director or (ii) is otherwise considered an
"outside director" for purposes of Section 162(m) of the Code. 

        (w)  "Participant" means a person to whom a Stock Award is granted pursuant to the Plan or, if
applicable, such other person who holds an outstanding Stock Award. 

        (x)   "Performance Criteria" means the one or more criteria that the Board shall select for purposes of
establishing the Performance Goals for a Performance Period. The Performance Criteria that shall be used to establish such Performance Goals may be based on any one of, or combination of, the
following: (i) earnings per share; (ii) earnings before interest, taxes and depreciation; (iii) earnings before interest, taxes, depreciation and amortization (EBITDA);
(iv) net earnings; (v) total shareholder return; (vi) return on equity; (vii) return on assets, investment, or capital employed; (viii) operating margin;
(ix) gross margin; (x) operating income; (xi) net income (before or after taxes); (xii) net operating income; (xiii) net operating income after tax;
(xiv) pre- and after-tax income; (xv) pre-tax profit; (xvi) operating cash flow; (xvii) sales or revenue targets;
(xviii) increases in revenue or product revenue; (xix) expenses and cost reduction goals; (xx) improvement in or attainment of expense levels; (xxi) improvement in or
attainment of working capital levels; (xxii) economic value added (or an equivalent metric); (xxiii) market share; (xxiv) cash flow; (xxv) cash flow per share;
(xxvi) share price performance; (xxvii) debt reduction; (xxviii) implementation or completion of projects or processes; (xxix) customer satisfaction; (xxx) total
stockholder return; (xxxi) stockholders' equity; and (xxxii) other measures of performance selected by the Board. Partial achievement of the specified criteria may result in the payment
or vesting corresponding to the degree of achievement as specified in the Stock Award Agreement. The Board shall, in its sole discretion, define the manner of calculating the Performance Criteria it
selects to use for such Performance Period. 

        (y)   "Performance Goals" means, for a Performance Period, the one or more goals established by the
Board for the Performance Period based upon the Performance Criteria. The Board is authorized 

A-3

 

at
any time in its sole discretion, to adjust or modify the calculation of a Performance Goal for such Performance Period in order to prevent the dilution or enlargement of the rights of Participants,
(a) in the event of, or in anticipation of, any unusual or extraordinary corporate item, transaction, event or development; (b) in recognition of, or in anticipation of, any other
unusual or nonrecurring events affecting the Company, or the financial statements of the Company, or in response to, or in anticipation of, changes in applicable laws, regulations, accounting
principles, or business conditions; or (c) in view of the Board's assessment of the business strategy of the Company, performance of comparable organizations, economic and business conditions,
and any other circumstances deemed relevant. Specifically, the Board is authorized to make adjustment in the method of calculating attainment of Performance Goals and objectives for a Performance
Period as follows: (i) to exclude the dilutive effects of acquisitions or joint ventures; (ii) to assume that any business divested by the Company achieved performance objectives at
targeted levels during the balance of a Performance Period following such divestiture; and (iii) to exclude the effect of any change in the outstanding shares of common stock of the Company by
reason of any stock dividend or split, stock repurchase, reorganization, recapitalization, merger, consolidation, spin-off, combination or exchange of shares or other similar corporate
change, or any distributions to common shareholders other than regular cash dividends. In addition, the Board is authorized to make adjustment in the method of calculating attainment of Performance
Goals and objectives for a Performance Period as follows: (i) to exclude restructuring and/or other nonrecurring charges; (ii) to exclude exchange rate effects, as applicable, for
non-U.S. dollar denominated net sales and operating earnings; (iii) to exclude the effects of changes to generally accepted accounting standards required by the Financial Accounting
Standards Board; (iv) to exclude the effects to any statutory adjustments to corporate tax rates; (v) to exclude the impact of any "extraordinary items" as determined under generally
accepted accounting principles; and (vi) to exclude any other unusual, non-recurring gain or loss or other extraordinary item. 

        (z)   "Performance Period" means the one or more periods of time, which may be of varying and
overlapping durations, as the Board may select, over which the attainment of one or more Performance Goals will be measured for the purpose of determining a Participant's right to and the payment of a
Stock Award. 

        (aa) "Plan" means this Rigel Pharmaceuticals, Inc. 2000 Equity Incentive Plan. 

        (bb) "Rule 16b-3" means Rule 16b-3 promulgated under the
Exchange Act or any successor to Rule 16b-3, as in effect from time to time. 

        (cc) "Securities Act" means the Securities Act of 1933, as amended. 

        (dd) "Stock Award" means any right granted under the Plan, including an Option, a stock bonus, a
right to acquire restricted stock, a stock unit award and a stock appreciation right. 

        (ee) "Stock Award Agreement" means a written agreement between the Company and a holder of a Stock
Award evidencing the terms and conditions of an individual Stock Award grant. Each Stock Award Agreement shall be subject to the terms and conditions of the Plan. 

        (ff)  "Ten Percent Stockholder" means a person who owns (or is deemed to own pursuant to
Section 424(d) of the Code) stock possessing more than ten percent (10%) of the total combined voting power of all classes of stock of the Company or of any of its Affiliates. 

3.     ADMINISTRATION.

        (a)   Administration by Board.    The Board shall administer the Plan unless and until the Board delegates
administration to a Committee, as provided in subsection 3(c). 

A-4

 

        (b)   Powers of Board.    The Board shall have the power, subject to, and within the limitations of, the express
provisions of the Plan: 

        (i)    To determine from time to time which of the persons eligible under the Plan shall be granted Stock Awards; when and how
each Stock Award shall be granted; what type or combination of types of Stock Award shall be granted; the provisions of each Stock Award granted (which need not be identical), including the time or
times when a person shall be permitted to receive Common Stock pursuant to a Stock Award; and the number of shares of Common Stock with respect to which a Stock Award shall be granted to each such
person. 

        (ii)   To construe and interpret the Plan and Stock Awards granted under it, and to establish, amend and revoke rules and
regulations for its administration. The Board, in the exercise of this power, may
correct any defect, omission or inconsistency in the Plan or in any Stock Award Agreement, in a manner and to the extent it shall deem necessary or expedient to make the Plan fully effective. 

        (iii) To amend the Plan or a Stock Award as provided in Section 12. 

        (iv)  To terminate or suspend the Plan as provided in Section 13. 

        (v)   Generally, to exercise such powers and to perform such acts as the Board deems necessary or expedient to promote the best
interests of the Company which are not in conflict with the provisions of the Plan. 

        (c)   Delegation to Committee. 

        (i)    General.    The Board may delegate administration of the Plan to a Committee or Committees of one (1) or
more members of the Board, and the term "Committee" shall apply to any person or persons to whom such authority has been delegated. If administration is delegated to a Committee, the Committee shall
have, in connection with the administration of the Plan, the powers theretofore possessed by the Board, including the power to delegate to a subcommittee any of the administrative powers the Committee
is authorized to exercise (and references in this Plan to the Board shall thereafter be to the Committee or subcommittee), subject, however, to such resolutions, not inconsistent with the provisions
of the Plan, as may be adopted from time to time by the Board. The Board may abolish the Committee at any time and revest in the Board the administration of the Plan. 

        (ii)   Committee Composition when Common Stock is Publicly Traded.    At such time as the Common Stock is publicly
traded, in the discretion of the Board, a Committee may consist solely of two or more Outside Directors, in accordance with Section 162(m) of the Code, and/or solely of two or more
Non-Employee Directors, in accordance with Rule 16b-3. Within the scope of such authority, the Board or the Committee may (1) delegate to a committee of one or
more members of the Board who are not Outside Directors the authority to grant Stock Awards to eligible persons who are either (a) not then Covered Employees and are not expected to be Covered
Employees at the time of recognition of income resulting from such Stock Award or (b) not persons with respect to whom the Company wishes to comply with Section 162(m) of the Code and/or
(2) delegate to a committee of one or more members of the Board who are not Non-Employee Directors the authority to grant Stock Awards to eligible persons who are not then subject
to Section 16 of the Exchange Act. 

        (d)   Effect of Board's Decision.    All determinations, interpretations and constructions made by the Board in good
faith shall not be subject to review by any person and shall be final, binding and conclusive on all persons. 

        (e)   Cancellation and Re-Grant of Stock Awards.    Notwithstanding anything to the contrary in the Plan,
neither the Board nor any Committee shall have the authority to: (i) reprice any outstanding Stock Awards under the Plan, (ii) cancel and re-grant any outstanding Stock
Awards under the Plan, or 

A-5

 

(iii) effect
any other action that is treated as a repricing under generally accepted accounting principles unless, in each case, the stockholders of the Company have approved such an action
within twelve (12) months prior to such an event. 

4.     SHARES SUBJECT TO THE PLAN.

        (a)   Share Reserve.    Subject to the provisions of subsection 11(a) relating to adjustments upon changes in
Common Stock, the shares of Common Stock that may be issued pursuant to Stock Awards shall not exceed in the aggregate 8,410,403 shares of Common Stock, which number consists of (i) 1,058,333
shares of Common Stock initially reserved for issuance under the Plan plus (ii) 1,600,000 shares of Common Stock approved by the Board in April 2003 and subsequently approved by the Company's
stockholders plus (iii) 388,889 shares of Common Stock that were originally reserved for issuance under the Non-Officer Plan (prior to the termination of such plan) as approved by
the Board in April 2003 and subsequently approved by the Company's stockholders plus (iv) 296,022 shares and 392,159 shares of Common Stock made available for issuance on December 2,
2003 and 2004, respectively, pursuant to the evergreen provision that was approved by the Board and the Company's stockholders in April 2003 (and subsequently terminated by the Board and stockholders
in April 2005) plus (v) 2,275,000 shares of Common Stock approved by the Board in April 2005 and subsequently approved by the Company's stockholders plus (vi) 500,000 shares of Common
Stock approved by the Board in April 2006 and subsequently approved by the Company's stockholders plus (vii) 1,900,000 shares of Common stock approved by the Board in January 2007 and
subsequently approved by the Company's stockholders plus (viii) 3,350,000 shares of Common stock approved by the Board in February 2008 and subsequently approved by the Company's stockholders. 

        (b)   Subject to subsection 4(c), the number of shares available for issuance under the Plan shall be reduced by:
(i) one (1) share for each share of stock issued pursuant to (A) an Option granted under Section 6, or (B) a Stock Appreciation Right granted under
subsection 7(d) with respect to which the strike price is at least one hundred percent (100%) of the Fair Market Value of the underlying Common Stock on the date of grant; and (ii) one
and five tenths (1.5) shares for each share of Common Stock issued pursuant to a Stock Bonus Award, Restricted Stock Award, Stock Unit Award or Performance Stock Award. 

        (c)   Reversion of Shares to the Share Reserve.  

         (i)    Shares Available For Subsequent Issuance.    If any (i) Stock Award, including any stock awards granted
under the
Non-Officer Plan prior to April 24, 2003, shall for any reason expire or otherwise terminate, in whole or in part, without having been exercised in full, (ii) shares of
Common Stock issued to a Participant pursuant to a Stock Award, including any shares of Common Stock issued pursuant to stock awards under the Non-Officer Plan prior to April 24,
2003, are forfeited to or repurchased by the Company, including any repurchase or forfeiture caused by the failure to meet a contingency or condition required for the vesting of such shares, or
(iii) Stock Award is settled in cash, then the shares of Common Stock not issued under such Stock Award, or forfeited to or repurchased by the Company, shall revert to and again become
available for issuance under the Plan. To the extent there is issued a share of Common Stock pursuant to a Stock Award that counted as one and five tenths (1.5) shares against the number of shares
available for issuance under the Plan pursuant to subsection 4(b) and such share of Common Stock again becomes available for issuance under the Plan pursuant to this subsection 4(c)(i),
then the number of shares of Common Stock available for issuance under the Plan shall increase by one and five tenths (1.5) shares. 

        (ii)   Shares Not Available For Subsequent Issuance.    If any shares subject to a Stock Award are not delivered to a
Participant because the Stock Award is exercised through a reduction of shares subject to the Stock Award (i.e., "net exercised"), the number of shares
that are not delivered to the Participant shall not remain available for issuance under the Plan. If any shares 

A-6

 

subject
to a Stock Award are not delivered to a Participant because such shares are withheld in satisfaction of the withholding of taxes incurred in connection with the exercise of an Option or stock
appreciation right, or the issuance of shares under a stock bonus award, restricted stock award or stock unit award, the number of shares that are not delivered to the Participant shall not remain
available for subsequent issuance under the Plan. If the exercise price of any Stock Award is satisfied by tendering shares of Common Stock held by the Participant (either by actual delivery or
attestation), then the number of shares so tendered shall not remain available for subsequent issuance under the Plan. 

        (d)   Source of Shares.    The shares of Common Stock subject to the Plan may be unissued shares or reacquired
shares, bought on the market or otherwise. 

5.     ELIGIBILITY.

        (a)   Eligibility for Specific Stock Awards.    Incentive Stock Options may be granted only to Employees. Stock
Awards other than Incentive Stock Options may be granted to Employees, Directors and Consultants. 

        (b)   Ten Percent Stockholders.    A Ten Percent Stockholder shall not be granted an Incentive Stock Option unless
the exercise price of such Option is at least one hundred ten percent (110%) of the Fair Market Value of the Common Stock at the date of grant and the Option is not exercisable after the expiration of
five (5) years from the date of grant. 

        (c)   Section 162(m) Limitation.    Subject to the provisions of Section 11 relating to adjustments
upon changes in the shares of Common Stock, no Employee shall be eligible to be granted Options covering more than one hundred sixty-six thousand six hundred sixty-six
(166,666) shares of Common Stock during any calendar year. 

        (d)   Consultants.  

         (i)    A Consultant shall not be eligible for the grant of a Stock Award if, at the time of grant, a Form S-8 Registration Statement
under the Securities Act ("Form S-8") is not available to register either the offer or the sale of the Company's securities to such Consultant because of the nature of the services
that the Consultant is providing to the Company, or because the Consultant is not a natural person, or as otherwise provided by the rules governing the use of Form S-8, unless the
Company determines both (i) that such grant (A) shall be registered in another manner under the Securities Act (e.g., on a
Form S-3 Registration Statement) or (B) does not require registration under the Securities Act in order to comply with the requirements of the Securities Act, if applicable,
and (ii) that such grant complies with the securities laws of all other relevant jurisdictions. 

        (ii)   Form S-8 generally is available to consultants and advisors only if (i) they are natural
persons; (ii) they provide bona fide services to the issuer, its parents, its majority-owned subsidiaries or majority-owned subsidiaries of the issuer's parent; and (iii) the services
are not in connection with the offer or sale of securities in a capital-raising transaction, and do not directly or indirectly promote or maintain a market for the issuer's securities. 

6.     OPTION PROVISIONS.

        Each Option shall be in such form and shall contain such terms and conditions as the Board shall deem appropriate. All Options shall be separately designated
Incentive Stock Options or Nonstatutory Stock Options at the time of grant, and, if certificates are issued, a separate certificate or certificates will be issued for shares of Common Stock purchased
on exercise of each type of Option. The provisions of separate Options need not be identical, but each Option shall include (through 

A-7

 

incorporation
of provisions hereof by reference in the Option or otherwise) the substance of each of the following provisions: 

        (a)   Term.    Subject to the provisions of subsection 5(b) regarding Ten Percent Stockholders, no Option
shall be exercisable after the expiration of ten (10) years from the date it was granted. 

        (b)   Exercise Price of an Incentive Stock Option.    Subject to the provisions of subsection 5(b) regarding
Ten Percent Stockholders, the exercise price of each Incentive Stock Option shall be not less than one hundred percent (100%) of the Fair Market Value of the Common Stock subject to the Option on the
date the Option is granted. Notwithstanding the foregoing, an Incentive Stock Option may be granted with an exercise price lower than that set forth in the preceding sentence if such Option is granted
pursuant to an assumption or substitution for another option in a manner satisfying the provisions of Section 424(a) of the Code. 

        (c)   Exercise Price of a Nonstatutory Stock Option.    The exercise price of each Nonstatutory Stock Option shall be
not less than one hundred percent (100%) of the Fair Market Value of the Common Stock subject to the Option on the date the Option is granted. Notwithstanding the foregoing, a Nonstatutory Stock
Option may be granted with an exercise price lower than that set forth in the preceding sentence if such Option is granted pursuant to an assumption or substitution for another option in a manner
satisfying the provisions of Section 424(a) of the Code. 

        (d)   Consideration.    The purchase price of Common Stock acquired pursuant to an Option shall be paid, to the
extent permitted by applicable statutes and regulations, either (i) in cash at the time the Option is exercised or (ii) at the discretion of the Board (1) by delivery to the
Company of other Common Stock; (2) according to a deferred payment or other similar arrangement with the Optionholder; (3) by a "net exercise" arrangement pursuant to which the Company
will reduce the number of shares of Common Stock issued upon exercise by the largest whole number of shares with a Fair Market Value that does not exceed the aggregate exercise price;  provided, however,
that the Company shall accept a cash or other payment from the Participant to the extent of any remaining balance of the aggregate
exercise price not satisfied by such holding back of whole shares; provided, further, however, that shares of Common Stock will no longer be outstanding
under an Option and will not be exercisable thereafter to the extent that (i) shares are used to pay the exercise price pursuant to the "net exercise," (ii) shares are delivered to the
Participant as a result of such exercise, and (iii) shares are withheld to satisfy tax withholding obligations; or (4) in any other form of legal consideration that may be acceptable to
the Board. Unless otherwise specifically provided in the Option, the purchase price of Common Stock acquired pursuant to an Option that is paid by delivery to the Company of other Common Stock
acquired, directly or indirectly from the Company, shall be paid only by shares of the Common Stock of the Company that have been held for more than six (6) months (or such longer or shorter
period of time required to avoid a charge to the Company's earnings for financial accounting purposes). At any time that the Company is incorporated in Delaware, payment of the Common Stock's "par
value," as defined in the Delaware General Corporation Law, shall not be made by deferred payment. 

        In
the case of any deferred payment arrangement, interest shall be compounded at least annually and shall be charged at the minimum rate of interest necessary to avoid (1) the
treatment as interest, under any applicable provisions of the Code, of any amounts other than amounts stated to be interest under the deferred payment arrangement and (2) the treatment of the
Option as a variable award for financial accounting purposes. 

        (e)   Transferability of an Incentive Stock Option.    An Incentive Stock Option shall not be transferable except by
will or by the laws of descent and distribution and shall be exercisable during the lifetime of the Optionholder only by the Optionholder. Notwithstanding the foregoing, the Optionholder may, by
delivering written notice to the Company, in a form satisfactory to the Company, designate a third party who, in the event of the death of the Optionholder, shall thereafter be entitled to exercise
the Option. 

A-8

 

  
        (f)    Transferability of a Nonstatutory Stock Option.    A Nonstatutory Stock Option shall be transferable to the
extent provided in the Option Agreement. If the Nonstatutory Stock Option does not provide for transferability, then the Nonstatutory Stock Option shall not be transferable except by will or by the
laws of descent and distribution and shall be exercisable during the lifetime of the Optionholder only by the Optionholder. Notwithstanding the foregoing, the Optionholder may, by delivering written
notice to the Company, in a form satisfactory to the Company, designate a third party who, in the event of the death of the Optionholder, shall thereafter be entitled to exercise the Option. 

        (g)   Vesting Generally.    The total number of shares of Common Stock subject to an Option may, but need not, vest
and therefore become exercisable in periodic installments that may, but need not, be equal. The Option may be subject to such other terms and conditions on the time or times when it may be exercised
(which may be based on performance or other criteria) as the Board may deem appropriate. The vesting provisions of individual Options may vary. The provisions of this subsection 6(g) are
subject to any Option provisions governing the minimum number of shares of Common Stock as to which an Option may be exercised. 

        (h)   Termination of Continuous Service.    In the event an Optionholder's Continuous Service terminates (other than
upon the Optionholder's death or Disability), the Optionholder may exercise his or her Option (to the extent that the Optionholder was entitled to exercise such Option as of the date of termination)
but only within such period of time ending on the earlier of (i) the date three (3) months following the termination of the Optionholder's Continuous Service (or such longer or shorter
period specified in the Option Agreement), or (ii) the expiration of the term of the Option as set forth in the Option Agreement. If, after termination, the Optionholder does not exercise his
or her Option within the time specified in the Option Agreement, the Option shall terminate. 

        (i)    Extension of Termination Date.    An Optionholder's Option Agreement may also provide that if the exercise of
the Option following the termination of the Optionholder's Continuous Service (other than upon the Optionholder's death or Disability) would be prohibited at any time solely because the issuance of
shares of Common Stock would violate the registration requirements under the Securities Act, then the Option shall terminate on the earlier of (i) the expiration of the term of the Option set
forth in the Option Agreement or (ii) the expiration of a period of three (3) months after the termination of the Optionholder's Continuous Service during which the exercise of the
Option would not be in violation of such registration requirements. 

        (j)    Disability of Optionholder.    In the event that an Optionholder's Continuous Service terminates as a result of
the Optionholder's Disability, the Optionholder may exercise his or her Option (to the extent that the Optionholder was entitled to exercise such Option as of the date of termination), but only within
such period of time ending on the earlier of (i) the date twelve (12) months following such termination (or such longer or shorter period specified in the Option Agreement) or
(ii) the expiration of the term of the Option as set forth in the Option Agreement. If, after termination, the Optionholder does not exercise his or her Option within the time specified herein,
the Option shall terminate. 

        (k)   Death of Optionholder.    In the event (i) an Optionholder's Continuous Service terminates as a result
of the Optionholder's death or (ii) the Optionholder dies within the period (if any) specified in the Option Agreement after the termination of the Optionholder's Continuous Service for a
reason other than death, then the Option may be exercised (to the extent the Optionholder was entitled to exercise such Option as of the date of death) by the Optionholder's estate, by a person who
acquired the right to exercise the Option by bequest or inheritance or by a person designated to exercise the Option upon the Optionholder's death pursuant to subsection 6(e) or 6(f), but only
within the period ending on the earlier of (1) the date eighteen (18) months following the date of death (or such longer or shorter period specified in the Option Agreement) or
(2) the expiration of the term of such Option 

A-9

 

as
set forth in the Option Agreement. If, after death, the Option is not exercised within the time specified herein, the Option shall terminate. 

        (l)    Early Exercise.    The Option may, but need not, include a provision whereby the Optionholder may elect at any
time before the Optionholder's Continuous Service terminates to exercise the Option as to any part or all of the shares of Common Stock subject to the Option prior to the full vesting of the Option.
Any unvested shares of Common Stock so purchased may be subject to a repurchase option in favor of the Company or to any other restriction the Board determines to be appropriate. The Company will not
exercise its repurchase option until at least six (6) months (or such longer or shorter period of time required to avoid a charge to earnings for financial accounting purposes) have elapsed
following exercise of the Option unless the Board otherwise specifically provides in the Option. 

7.     PROVISIONS OF STOCK AWARDS OTHER THAN OPTIONS.

        (a)   Stock Bonus Awards.    Each stock bonus agreement shall be in such form and shall contain such terms and
conditions as the Board shall deem appropriate. The terms and conditions of stock bonus agreements may change from time to time, and the terms and conditions of separate stock bonus agreements need
not be identical, but each stock bonus agreement shall include (through incorporation of provisions hereof by reference in the agreement or otherwise) the substance of each of the following
provisions: 

        (i)    Consideration.    A stock bonus may be awarded in consideration for past services actually rendered to the
Company or an Affiliate for its benefit. 

        (ii)   Vesting.    Shares of Common Stock awarded under the stock bonus agreement may, but need not, be subject to a
share repurchase option in favor of the Company in accordance with a vesting schedule to be determined by the Board. 

        (iii) Termination of Participant's Continuous Service.    In the event a Participant's Continuous Service
terminates, the Company may reacquire any or all of the shares of Common Stock held by the Participant which have not vested as of the date of termination under the terms of the stock bonus agreement.
The Company will not exercise its repurchase option until at least six (6) months (or such longer or shorter period of time required to avoid a change to earnings for financial accounting
purposes) have elapsed following receipt of the stock bonus unless otherwise specifically provided in the stock bonus agreement. 

        (iv)  Transferability.    Rights to acquire shares of Common Stock under the stock bonus agreement shall be
transferable by the Participant only upon such terms and conditions as are set forth in the stock bonus agreement, as the Board shall determine in its discretion, so long as Common Stock awarded under
the stock bonus agreement remains subject to the terms of the stock bonus agreement. 

        (b)   Restricted Stock Awards.    Each restricted stock purchase agreement shall be in such form and shall contain
such terms and conditions as the Board shall deem appropriate. The terms and conditions of the restricted stock purchase agreements may change from time to time, and the terms and conditions of
separate restricted stock purchase agreements need not be identical, but each restricted stock purchase agreement shall include (through incorporation of provisions hereof by reference in the
agreement or otherwise) the substance of each of the following provisions: 

        (i)    Purchase Price.    The purchase price under each restricted stock purchase agreement shall be such amount as
the Board shall determine and designate in such restricted stock purchase agreement. The purchase price shall not be less than eighty-five percent (85%) of the Common Stock's Fair Market
Value on the date such award is made or at the time the purchase is consummated. 

A-10

 

        (ii)   Consideration.    The purchase price of Common Stock acquired pursuant to the restricted stock purchase
agreement shall be paid either: (i) in cash at the time of purchase; (ii) at the discretion of the Board, according to a deferred payment or other similar arrangement with the
Participant; or (iii) in any
other form of legal consideration that may be acceptable to the Board in its discretion; provided, however, that at any time that the Company is
incorporated in Delaware, then payment of the Common Stock's "par value," as defined in the Delaware General Corporation Law, shall not be made by deferred payment. 

        (iii) Vesting.    Shares of Common Stock acquired under the restricted stock purchase agreement may, but need not,
be subject to a share repurchase option in favor of the Company in accordance with a vesting schedule to be determined by the Board. 

        (iv)  Termination of Participant's Continuous Service.    In the event a Participant's Continuous Service
terminates, the Company may repurchase or otherwise reacquire any or all of the shares of Common Stock held by the Participant that have not vested as of the date of termination under the terms of the
restricted stock purchase agreement. The Company will not exercise its repurchase option until at least six (6) months (or such longer or shorter period of time required to avoid a charge to
earnings for financial accounting purposes) have elapsed following the purchase of the restricted stock unless otherwise provided in the restricted stock purchase agreement. 

        (v)   Transferability.    Rights to acquire shares of Common Stock under the restricted stock purchase agreement
shall be transferable by the Participant only upon such terms and conditions as are set forth in the restricted stock purchase agreement, as the Board shall determine in its discretion, so long as
Common Stock awarded under the restricted stock purchase agreement remains subject to the terms of the restricted stock purchase agreement. 

        (c)   Stock Unit Awards.    Each stock unit award agreement shall be in such form and shall contain such terms and
conditions as the Board shall deem appropriate. The terms and conditions of stock unit award agreements may change from time to time, and the terms and conditions of separate stock unit award
agreements need not be identical, provided, however, that each stock unit award agreement shall include (through incorporation of the provisions hereof
by reference in the agreement or otherwise) the substance of each of the following provisions: 

        (i)    Consideration.    At the time of grant of a stock unit award, the Board will determine the consideration, if
any, to be paid by the Participant upon delivery of each share of Common Stock subject to the stock unit award. The consideration to be paid (if any) by the Participant for each share of Common Stock
subject to a stock unit award may be paid in any form of legal consideration that may be acceptable to the Board in its sole discretion and permissible under applicable law. 

        (ii)   Vesting.    At the time of the grant of a stock unit award, the Board may impose such restrictions or
conditions to the vesting of the stock unit award as it, in its sole discretion, deems appropriate. 

        (iii) Payment.    A stock unit award may be settled by the delivery of shares of Common Stock, their cash
equivalent, any combination thereof or in any other form of consideration, as determined by the Board and contained in the stock unit award agreement. 

        (iv)  Additional Restrictions.    At the time of the grant of a stock unit award, the Board, as it deems
appropriate, may impose such restrictions or conditions that delay the delivery of the shares of Common Stock (or their cash equivalent) subject to a stock unit award after the vesting of such stock
unit award. 

A-11

 

        (v)   Dividend Equivalents.    Dividend equivalents may be credited in respect of shares of Common Stock covered by a
stock unit award, as determined by the Board and contained in the stock unit award agreement. At the sole discretion of the Board, such dividend equivalents may be converted into additional shares of
Common Stock covered by the stock unit award in such manner as determined by the Board. Any additional shares covered by the stock unit award credited by reason of such dividend equivalents will be
subject to all the terms and conditions of the underlying stock unit award agreement to which they relate. 

        (vi)  Termination of Participant's Continuous Service.    Except as otherwise provided in the applicable stock unit
award agreement, such portion of the stock unit award that has not vested will be forfeited upon the Participant's termination of Continuous Service. 

        (d)   Stock Appreciation Rights.    Each stock appreciation right agreement shall be in such form and shall contain
such terms and conditions as the Board shall deem appropriate. The terms and conditions of stock appreciation right agreements may change from time to time, and the terms and conditions of separate
stock appreciation right agreements need not be identical; provided, however, that each stock appreciation right agreement shall include (through
incorporation of the provisions hereof by reference in the agreement or otherwise) the substance of each of the following provisions: 

        (i)    Strike Price and Calculation of Appreciation.    Each stock appreciation right will be denominated in shares of
Common Stock equivalents. The appreciation distribution payable on the exercise of a stock appreciation right will be not greater than an amount equal to the excess of (i) the aggregate Fair
Market Value (on the date of the exercise of the stock appreciation right) of a number of shares of Common Stock equal to the number of shares of Common Stock equivalents in which the Participant is
vested under such stock appreciation right, and with respect to which the Participant is exercising the stock appreciation right on such date, over (ii) an amount (the strike price) that will
be determined by the Board at the time of grant of the stock appreciation right. 

        (ii)   Vesting.    At the time of the grant of a stock appreciation right, the Board may impose such restrictions or
conditions to the vesting of such stock appreciation right as it, in its sole discretion, deems appropriate. 

        (iii) Exercise.    To exercise any outstanding stock appreciation right, the Participant must provide written
notice of exercise to the Company in compliance with the provisions of the stock appreciation right agreement evidencing such stock appreciation right. 

        (iv)  Payment.    The appreciation distribution in respect to a stock appreciation right may be paid in Common
Stock, in cash, in any combination of the two or in any other form of consideration, as determined by the Board and contained in the stock appreciation right agreement evidencing such stock
appreciation right. 

        (v)   Termination of Continuous Service.    In the event that a Participant's Continuous Service terminates, the
Participant may exercise his or her stock appreciation right (to the extent that the Participant was entitled to exercise such stock appreciation right as of the date of termination) but only within
such period of time ending on the earlier of (i) the date three (3) months following the termination of the Participant's Continuous Service (or such longer or shorter period specified
in the stock appreciation right agreement), or (ii) the expiration of the term of the stock appreciation right as set forth in the stock appreciation right agreement. If, after termination, the
Participant does not exercise his or her stock appreciation right within the time specified herein or in the stock appreciation right agreement (as applicable), the stock appreciation right shall
terminate. 

A-12

 

8.     COVENANTS OF THE COMPANY.

        (a)   Availability of Shares.    During the terms of the Stock Awards, the Company shall keep available at all times
the number of shares of Common Stock required to satisfy such Stock Awards. 

        (b)   Securities Law Compliance.    The Company shall seek to obtain from each regulatory commission or agency having
jurisdiction over the Plan such authority as may be required to grant Stock Awards and to issue and sell shares of Common Stock upon exercise of the Stock Awards; provided,
however, that this undertaking shall not require the Company to register under the Securities Act the Plan, any Stock Award or any Common Stock issued or issuable pursuant to
any such Stock Award. If, after reasonable efforts, the Company is unable to obtain from any such regulatory commission or agency the authority which counsel for the Company deems necessary for the
lawful issuance and sale of Common Stock under the Plan, the Company shall be relieved from any liability for failure to issue and sell Common Stock upon exercise of such Stock Awards unless and until
such authority is obtained. 

9.     USE OF PROCEEDS FROM STOCK.

        Proceeds from the sale of Common Stock pursuant to Stock Awards shall constitute general funds of the Company. 

10.   MISCELLANEOUS.

        (a)   Acceleration of Exercisability and Vesting.    The Board shall have the power to accelerate the time at which a
Stock Award may first be exercised or the time during which a Stock Award or any part thereof will vest in accordance with the Plan, notwithstanding the provisions in the Stock Award stating the time
at which it may first be exercised or the time during which it will vest. 

        (b)   Stockholder Rights.    No Participant shall be deemed to be the holder of, or to have any of the rights of a
holder with respect to, any shares of Common Stock subject to such Stock Award unless and until such Participant has satisfied all requirements for exercise of the Stock Award pursuant to its terms. 

        (c)   No Employment or other Service Rights.    Nothing in the Plan or any instrument executed or Stock Award granted
pursuant thereto shall confer upon any Participant any right to continue to serve the Company or an Affiliate in the capacity in effect at the time the Stock Award was granted or shall affect the
right of the Company or an Affiliate to terminate (i) the employment of an Employee with or without notice and with or without cause, (ii) the service of a Consultant pursuant to the
terms of such Consultant's agreement with the Company or an Affiliate or (iii) the service of a Director pursuant to the Bylaws of the Company or an Affiliate, and any applicable provisions of
the corporate law of the state in which the Company or the Affiliate is incorporated, as the case may be. 

        (d)   Incentive Stock Option $100,000 Limitation.    To the extent that the aggregate Fair Market Value (determined
at the time of grant) of Common Stock with respect to which Incentive Stock Options are exercisable for the first time by any Optionholder during any calendar year (under all plans of the Company and
its Affiliates) exceeds one hundred thousand dollars ($100,000), the Options or portions thereof which exceed such limit (according to the order in which they were granted) shall be treated as
Nonstatutory Stock Options. 

        (e)   Investment Assurances.    The Company may require a Participant, as a condition of exercising or acquiring
Common Stock under any Stock Award, (i) to give written assurances satisfactory to the Company as to the Participant's knowledge and experience in financial and business matters and/or to
employ a purchaser representative reasonably satisfactory to the Company who is knowledgeable and experienced in financial and business matters and that he or she is capable of evaluating, alone or
together with the purchaser representative, the merits and risks of exercising the Stock Award; and 

A-13

 

(ii) to
give written assurances satisfactory to the Company stating that the Participant is acquiring Common Stock subject to the Stock Award for the Participant's own account and not with any
present intention of selling or otherwise distributing the Common Stock. The foregoing requirements, and any assurances given pursuant to such requirements, shall be inoperative if (1) the
issuance of the shares of Common Stock upon the exercise or acquisition of Common Stock under the Stock Award has been registered under a then currently effective registration statement under the
Securities Act or (2) as to any particular requirement, a determination is made by counsel for the Company that such requirement need not be met in the circumstances under the then applicable
securities laws. The Company may, upon advice of counsel to the Company, place legends on stock certificates issued under the Plan as such counsel deems necessary or appropriate in order to comply
with applicable securities laws, including, but not limited to, legends restricting the transfer of the Common Stock. 

        (f)    Withholding Obligations.    To the extent provided by the terms of a Stock Award Agreement, the Participant may
satisfy any federal, state or local tax withholding obligation relating to the exercise or acquisition of Common Stock under a Stock Award by any of the following means (in addition to the Company's
right to withhold from any compensation paid to the Participant by the Company) or by a combination of such means: (i) tendering a cash payment; (ii) authorizing the Company to withhold
shares of Common Stock from the shares of Common Stock otherwise issuable to the Participant as a result of the exercise or acquisition of Common Stock under the Stock Award,  provided, however, that no
shares of Common Stock are withheld with a value exceeding the minimum amount of tax required to be withheld by law (or such
lesser amount as may be necessary to avoid variable award accounting); or (iii) delivering to the Company owned and unencumbered shares of Common Stock of the Company that have been held for
more than six (6) months (or such longer or shorter period of time required to avoid a charge to the Company's earnings for financial accounting purposes). 

        (g)   Performance Stock Awards.    A Stock Award may be granted, may vest, or may be exercised based upon service
conditions, upon the attainment during a Performance Period of certain Performance Goals, or both. The length of any Performance Period, the Performance Goals to be achieved during the Performance
Period, and the measure of whether and to what degree such Performance Goals have been attained shall be conclusively determined by the Board in its sole discretion. The maximum benefit to be received
by any individual in any calendar year attributable to Stock Awards described in this subsection 10(g) shall not exceed the value of one hundred sixty-six thousand six hundred
sixty-six (166,666) shares of Common Stock. 

11.   ADJUSTMENTS UPON CHANGES IN STOCK.

        (a)   Capitalization Adjustments.    If any change is made in the Common Stock subject to the Plan, or subject to any
Stock Award, without the receipt of consideration by the Company (through merger, consolidation, reorganization, recapitalization, reincorporation, stock dividend, dividend in property other than
cash, stock split, liquidating dividend, combination of shares, exchange of shares, change in corporate structure or other transaction not involving the receipt of consideration by the Company), the
Plan will be appropriately adjusted in the class(es) and maximum number of securities subject to the Plan pursuant to subsection 4(a) and the maximum number of securities subject to award to
any person pursuant to subsection 5(c) and 10(g), and the outstanding Stock Awards will be appropriately adjusted in the class(es) and number of securities and price per share of Common Stock
subject to such outstanding Stock Awards. The Board shall make such adjustments, and its determination shall be final, binding and conclusive. (The conversion of any convertible securities of the
Company shall not be treated as a transaction "without receipt of consideration" by the Company.) 

        (b)   Dissolution or Liquidation.    In the event of a dissolution or liquidation of the Company, then all
outstanding Stock Awards shall terminate immediately prior to such event, and shares of Common Stock subject to the Company's repurchase option may be repurchased by the Company notwithstanding the
fact that the holder of such stock is still in Continuous Service. Notwithstanding 

A-14

 

the
foregoing, Options granted under the 1997 Stock Option Plan shall be subject to subsection 11(c) below in the event of a dissolution or liquidation of the Company. 

        (c)   Corporate Transaction.    In the event of (i) a sale, lease or other disposition of all or substantially
all of the securities or assets of the Company, (ii) a merger or consolidation in which the Company is not the surviving corporation or (iii) a reverse merger in which the Company is the
surviving corporation but the shares of Common Stock outstanding immediately preceding the merger are converted by virtue of the merger into other property, whether in the form of securities, cash or
otherwise, then any surviving corporation or acquiring corporation may assume any Stock Awards outstanding under the Plan or may substitute similar stock awards (including an award to acquire the same
consideration paid to the stockholders in the transaction described in this subsection 11(c)) for those outstanding under the Plan. In the event any surviving corporation or acquiring
corporation does not assume such Stock Awards or substitute similar stock awards for those outstanding under the Plan, then with respect to Stock Awards held by Participants whose Continuous Service
has not terminated, the vesting of such Stock Awards (and, if applicable, the time during which such Stock Awards may be exercised) shall be accelerated in full, and the Stock Awards shall terminate
if not exercised (if applicable) at or prior to such event. With respect to any other Stock Awards outstanding under the Plan, such Stock Awards shall terminate if not exercised (if applicable) prior
to such event. 

12.   AMENDMENT OF THE PLAN AND STOCK AWARDS.

        (a)   Amendment of Plan.    The Board at any time, and from time to time, may amend the Plan. However, except as
provided in Section 11 relating to adjustments upon changes in Common Stock, no amendment shall be effective unless approved by the stockholders of the Company to the extent stockholder
approval is necessary to satisfy the requirements of Section 422 of the Code, Rule 16b-3 or any Nasdaq or securities exchange listing requirements. 

        (b)   Stockholder Approval.    The Board may, in its sole discretion, submit any other amendment to the Plan for
stockholder approval, including, but not limited to, amendments to the Plan intended to satisfy the requirements of Section 162(m) of the Code and the regulations thereunder regarding the
exclusion of performance-based compensation from the limit on corporate deductibility of compensation paid to certain executive officers. 

        (c)   Contemplated Amendments.    It is expressly contemplated that the Board may amend the Plan in any respect the
Board deems necessary or advisable to provide eligible Employees with the maximum benefits provided or to be provided under the provisions of the Code and the regulations promulgated thereunder
relating to Incentive Stock Options and/or to bring the Plan and/or Incentive Stock Options granted under it into compliance therewith. 

        (d)   No Impairment of Rights.    Rights under any Stock Award granted before amendment of the Plan shall not be
impaired by any amendment of the Plan unless (i) the Company requests the consent of the Participant and (ii) the Participant consents in writing. 

        (e)   Amendment of Stock Awards.    The Board at any time, and from time to time, may amend the terms of any one or
more Stock Awards; provided, however, that the rights under any Stock Award shall not be impaired by any such amendment unless (i) the Company
requests the consent of the Participant and (ii) the Participant consents in writing. 

13.   TERMINATION OR SUSPENSION OF THE PLAN.

        (a)   Plan Term.    Unless sooner terminated by the Board pursuant to Section 3, the Plan shall automatically
terminate on the day before the tenth (10th) anniversary of the date the Plan is adopted by the Board or approved by the stockholders of the Company, whichever is earlier. No Stock Awards may be
granted under the Plan while the Plan is suspended or after it is terminated. 

A-15

 

        (b)   No Impairment of Rights.    Suspension or termination of the Plan shall not impair rights and obligations under
any Stock Award granted while the Plan is in effect except with the written consent of the Participant. 

14.   EFFECTIVE DATE OF PLAN.

        The Plan shall become effective upon its adoption by the Board, but no Stock Award shall be exercised (or, in the case of a stock bonus, shall be granted) unless
and until the Plan has been approved by the stockholders of the Company, which approval shall be within twelve (12) months before or after the date the Plan is adopted by the Board. 

15.   CHOICE OF LAW.

        The law of the State of Delaware shall govern all questions concerning the construction, validity and interpretation of this Plan, without regard to such state's
conflict of laws rules. 

A-16

 

  APPENDIX A TO 2000 EQUITY

INCENTIVE PLAN  

RIGEL PHARMACEUTICALS, INC.

2001 NON-OFFICER EQUITY INCENTIVE PLAN
ADOPTED JULY 19, 2001
AMENDED DECEMBER 13, 2002
STOCKHOLDER APPROVAL NOT REQUIRED

1.     PURPOSES.

        (a)   Eligible Stock Award Recipients.    The persons eligible to receive Stock Awards are the Employees (other than
Officers) and Consultants of the Company and its Affiliates. 

        (b)   Available Stock Awards.    The purpose of the Plan is to provide a means by which eligible recipients of Stock
Awards may be given an opportunity to benefit from increases in value of the Common Stock through the granting of the following Stock Awards: (i) Nonstatutory Stock Options, (ii) stock
bonus awards and (iii) rights to acquire restricted stock. 

        (c)   General Purpose.    The Company, by means of the Plan, seeks to retain the services of the group of persons
eligible to receive Stock Awards, to secure and retain the services of new members of this group and to provide incentives for such persons to exert maximum efforts for the success of the Company and
its Affiliates. 

2.     DEFINITIONS.

        (a)   "Affiliate" means any parent corporation or subsidiary corporation of the Company, whether now or
hereafter existing, as those terms are defined in Sections 424(e) and (f), respectively, of the Code. 

        (b)   "Board" means the Board of Directors of the Company. 

        (c)   "Code" means the Internal Revenue Code of 1986, as amended. 

        (d)   "Committee" means a committee of one or more members of the Board appointed by the Board in
accordance with Section 3(c). 

        (e)   "Common Stock" means the common stock of the Company. 

        (f)    "Company" means Rigel Pharmaceuticals, Inc., a Delaware corporation. 

        (g)   "Consultant" means any person, including an advisor, engaged by the Company or an Affiliate to
render consulting or advisory services and who is compensated for such services. However, the term "Consultant" shall not include either Directors who are not compensated by the Company for their
services as Directors or Directors who are merely paid a director's fee by the Company for their services as Directors. 

        (h)   "Continuous Service" means that the Participant's service with the Company or an Affiliate,
whether as an Employee, Director or Consultant, is not interrupted or terminated. The Participant's Continuous Service shall not be deemed to have terminated merely because of a change in the capacity
in which the Participant renders service to the Company or an Affiliate as an Employee, Consultant or Director or a change in the entity for which the Participant renders such service, provided that
there is no interruption or termination of the Participant's Continuous Service. For example, a change in status from an Employee of the Company to a Consultant of an Affiliate or a Director will not
constitute an interruption of Continuous Service. The Board or the chief executive officer of the Company, in that party's sole discretion, may determine whether Continuous Service shall be considered
interrupted in 

A-A-1

 

the
case of any leave of absence approved by that party, including sick leave, military leave or any other personal leave. 

        (i)    "Director" means a member of the Board of Directors of the Company. 

        (j)    "Disability" means the inability of a person, in the opinion of a qualified physician acceptable
to the Company, to perform the major duties of such person's position with the Company or with an Affiliate because of the sickness or injury of such person. 

        (k)   "Employee" means any person employed by the Company or an Affiliate. Mere service as a Director
or payment of a director's fee by the Company or an Affiliate shall not be sufficient to constitute "employment" by the Company or an Affiliate. 

        (l)    "Exchange Act" means the Securities Exchange Act of 1934, as amended. 

        (m)  "Fair Market Value" means, as of any date, the value of the Common Stock determined as follows: 

        (i)    If the Common Stock is listed on any established stock exchange or traded on the Nasdaq National Market or the Nasdaq
SmallCap Market, the Fair Market Value of a share of Common Stock shall be the closing sales price for such stock (or the closing bid if no sales were reported) as quoted on such exchange or market
(or the exchange or market with the greatest volume of trading in the Common Stock) on the day before the date of grant (the "determination date", or if the determination date is not a market trading
day, then the last market trading day prior to the determination, as reported in The Wall Street Journal or such other source as the Board deems
reliable. 

        (ii)   In the absence of such markets for the Common Stock, the Fair Market Value shall be determined in good faith by the
Board. 

        (n)   "Non-Employee Director" means a Director who either (i) is not a current
Employee or Officer of the Company or its parent or a subsidiary, does not receive compensation (directly or indirectly) from the Company or its parent or a subsidiary for services rendered as a
consultant or in any capacity other than as a Director (except for an amount as to which disclosure would not be required under Item 404(a) of Regulation S-K promulgated
under the federal securities laws ("Regulation S-K")), does not possess an interest in any other transaction as to which disclosure would be required under Item 404(a) of
Regulation S-K and is not engaged in a business relationship as to which disclosure would be required under Item 404(b) of Regulation S-K; or
(ii) is otherwise considered a "non-employee director" for purposes of Rule 16b-3. 

        (o)   "Nonstatutory Stock Option" means an Option not intended to qualify as an "incentive stock
option" within the meaning of Section 422 of the Code and the regulations promulgated thereunder. 

        (p)   "Officer" means a person who possesses the authority of an "officer" as that term is used in
Rule 4460(i)(1)(A) of the Rules of the National Association of Securities Dealers, Inc. For purposes of the Plan, a person employed by the Company in the position of "Vice President" or
higher shall be classified as an "Officer" unless the Board or Committee expressly finds that such person does not possess the authority of an "officer" as that term is used in
Rule 4460(i)(1)(A) of the Rules of the National Association of Securities Dealers, Inc. 

        (q)   "Option" means a Nonstatutory Stock Option granted pursuant to the Plan. 

        (r)   "Option Agreement" means a written agreement between the Company and an Optionholder evidencing
the terms and conditions of an individual Option grant. Each Option Agreement shall be subject to the terms and conditions of the Plan. 

A-A-2

 

        (s)   "Optionholder" means a person to whom an Option is granted pursuant to the Plan or, if
applicable, such other person who holds an outstanding Option. 

        (t)    "Participant" means a person to whom a Stock Award is granted pursuant to the Plan or, if
applicable, such other person who holds an outstanding Stock Award. 

        (u)   "Plan" means this Rigel Pharmaceuticals, Inc. 2001 Non-Officer Equity
Incentive Plan. 

        (v)   "Rule 16b-3" means Rule 16b-3 promulgated under the
Exchange Act or any successor to Rule 16b-3, as in effect from time to time. 

        (w)  "Securities Act" means the Securities Act of 1933, as amended. 

        (x)   "Stock Award" means any right granted under the Plan, including an Option, a restricted stock
purchase award and a stock bonus award. 

        (y)   "Stock Award Agreement" means a written agreement between the Company and a holder of a Stock
Award evidencing the terms and conditions of an individual Stock Award grant. Each Stock Award Agreement shall be subject to the terms and conditions of the Plan. 

3.     ADMINISTRATION.

        (a)   Administration by Board.    The Board shall administer the Plan unless and until the Board delegates
administration to a Committee, as provided in Section 3(c). 

        (b)   Powers of Board.    The Board shall have the power, subject to, and within the limitations of, the express
provisions of the Plan: 

        (i)    To determine from time to time which of the persons eligible under the Plan shall be granted Stock Awards; when and how
each Stock Award shall be granted; what type or combination of types of Stock Award shall be granted; the provisions of each Stock Award granted, including the time or times when a person shall be
permitted to receive Common Stock pursuant to a Stock Award; and the number of shares of Common Stock with respect to which a Stock Award shall be granted to each such person. 

        (ii)   To construe and interpret the Plan and Stock Awards granted under it, and to establish, amend and revoke rules and
regulations for its administration. The Board, in the exercise of this power, may
correct any defect, omission or inconsistency in the Plan or in any Stock Award Agreement, in a manner and to the extent it shall deem necessary or expedient to make the Plan fully effective. 

        (iii) To effect, at any time and from time to time, with the consent of any adversely affected Optionholder, (1) the
reduction of the exercise price of any outstanding Option under the Plan, (2) the cancellation of any outstanding Option under the Plan and the grant in substitution therefor of (A) a
new Option under the Plan covering the same or a different number of shares of Common Stock, (B) a stock bonus, (C) the right to acquire restricted stock, and/or (D) cash, or
(3) any other action that is treated as a repricing under generally accepted accounting principles. 

        (iv)  To amend the Plan or a Stock Award as provided in Section 12. 

        (v)   Generally, to exercise such powers and to perform such acts as the Board deems necessary or expedient to promote the best
interests of the Company which are not in conflict with the provisions of the Plan. 

        (c)   Delegation to Committee.  

         (i)    General.    The Board may delegate administration of the Plan to a Committee or Committees of one (1) or
more members of the
Board, and the term "Committee" shall apply to 

A-A-3

 

any
person or persons to whom such authority has been delegated. If administration is delegated to a Committee, the Committee shall have, in connection with the administration of the Plan, the powers
theretofore possessed by the Board, including the power to delegate to a subcommittee any of the administrative powers the Committee is authorized to exercise (and references in this Plan to the Board
shall thereafter be to the Committee or subcommittee), subject, however, to such resolutions, not inconsistent with the provisions of the Plan, as may be adopted from time to time by the Board. The
Board may abolish the Committee at any time and revest in the Board the administration of the Plan. 

        (ii)   Committee Composition when Common Stock is Publicly Traded.    At such time as the Common Stock is publicly
traded, in the discretion of the Board, a Committee may consist solely of two or more Non-Employee Directors, in accordance with Rule 16b-3. Within the scope of such
authority, the Board or the Committee may delegate to a committee of one or more members of the Board who are not Non-Employee Directors the authority to grant Stock Awards to eligible
persons who are not then subject to Section 16 of the Exchange Act. 

        (d)   Effect of Board's Decision.    All determinations, interpretations and constructions made by the Board in good
faith shall not be subject to review by any person and shall be final, binding and conclusive on all persons. 

4.     SHARES SUBJECT TO THE PLAN.

        (a)   Share Reserve.    Subject to the provisions of Section 11 relating to adjustments upon changes in Common
Stock, the Common Stock that may be issued pursuant to Stock Awards shall not exceed in the aggregate three million five hundred thousand (3,500,000) shares of Common Stock. 

        (b)   Reversion of Shares to the Share Reserve.    If any Nonstatutory Stock Option shall for any reason expire or
otherwise terminate, in whole or in part, without having been exercised in full, the shares of Common Stock not acquired under such Nonstatutory Stock Option shall revert to and again become available
for issuance under the Plan. 

        (c)   Source of Shares.    The shares of Common Stock subject to the Plan may be unissued shares or reacquired
shares, bought on the market or otherwise. 

5.     ELIGIBILITY.

        (a)   Eligibility for Specific Stock Awards.    Stock Awards may be granted to Employees, who are not Officers, and
Consultants; provided, however, that Officers who are not previously employed by the Company may be granted Stock Awards as an inducement essential to
such individuals entering into employment contracts with the Company. 

        (b)   Consultants.  

         (i)    A Consultant shall not be eligible for the grant of a Stock Award if, at the time of grant, a Form S-8 Registration Statement
under the Securities Act ("Form S-8") is not available to register either the offer or the sale of the Company's securities to such Consultant
because of the nature of the services that the Consultant is providing to the Company, or because the Consultant is not a natural person, or as otherwise provided by the rules governing the use of
Form S-8, unless the Company determines both (i) that such grant (A) shall be registered in another manner under the Securities Act
(e.g., on a Form S-3 Registration Statement) or (B) does not require registration under the Securities Act in order to
comply with the requirements of the Securities Act, if applicable, and (ii) that such grant complies with the securities laws of all other relevant jurisdictions. 

A-A-4

 

        (ii)   Form S-8 generally is available to consultants and advisors only if (i) they are natural
persons; (ii) they provide bona fide services to the issuer, its parents, its majority-owned subsidiaries or majority-owned subsidiaries of the issuer's parent; and (iii) the services
are not in connection with the offer or sale of securities in a capital-raising transaction, and do not directly or indirectly promote or maintain a market for the issuer's securities. 

6.     OPTION PROVISIONS.

        Each Option shall be in such form and shall contain such terms and conditions as the Board shall deem appropriate. The provisions of separate Options shall
include (through incorporation of provisions hereof by reference in the Option or otherwise) the substance of each of the following provisions: 

        (a)   Term.    The term of an Option shall not exceed 10 years, either at the time of grant of the Option or
as the Option may be amended thereafter. 

        (b)   Exercise Price of a Nonstatutory Stock Option.    The exercise price of each Nonstatutory Stock Option shall be
not less than the Fair Market Value of the Common Stock subject to the Option on the date the Option is granted. 

        (c)   Consideration.    The purchase price of Common Stock acquired pursuant to an Option shall be paid, to the
extent permitted by applicable statutes and regulations, either (i) in cash or by check at the time the Option is exercised or (ii) at the discretion of the Board at the time of the
grant of the Option or at any time prior to the time of exercise in the case of a Nonstatutory Stock Option (1) by delivery to the Company of other Common Stock, (2) according to a
deferred payment or other similar arrangement with the Optionholder or (3) in any other form of legal consideration that may be acceptable to the Board. Unless otherwise specifically provided
in the Option, the purchase price of Common Stock acquired pursuant to an Option that is paid by delivery to the Company of other Common Stock acquired, directly or indirectly from the Company, shall
be paid only by shares of the Common Stock of the Company that have been held for more than six (6) months (or such longer or shorter period of time required to avoid a charge to earnings for
financial accounting purposes). At any time that the Company is incorporated in Delaware, payment of the Common Stock's "par value," as defined in the Delaware General Corporation Law, shall not be
made by deferred payment. 

        In
the case of any deferred payment arrangement, interest shall be compounded at least annually and shall be charged at the market rate of interest necessary to avoid a charge to
earnings for financial accounting purposes. 

        (d)   Transferability of a Nonstatutory Stock Option.    A Nonstatutory Stock Option shall not be transferable except
by will or by the laws of descent and distribution and shall be exercisable during the lifetime of the Optionholder only by the Optionholder. Notwithstanding the foregoing, the Optionholder may, by
delivering written notice to the Company, in a form satisfactory to the Company, designate a third party who, in the event of the death of the Optionholder, shall thereafter be entitled to exercise
the Option. 

        (e)   Vesting Generally.    Each Option shall be evidenced by an Option Agreement executed by the Company and the
Optionholder. The total number of shares of Common Stock subject to an Option may vest and therefore become exercisable as set-forth in the Option Agreement. The Option may be subject to
such other terms and conditions on the time or times when it may be exercised (which may be based on performance or other criteria) as the Board may deem appropriate. The provisions of this
Section 6(e) are subject to any Option provisions governing the minimum number of shares of Common Stock as to which an Option may be exercised. 

        (f)    Termination of Continuous Service.    In the event an Optionholder's Continuous Service terminates for any
reason other than upon the Optionholder's death or Disability, the Optionholder 

A-A-5

 

may
exercise his or her Option (to the extent that the Optionholder was entitled to exercise such Option as of the date of termination or as otherwise permitted by the Company) but only within such
period of time ending on the earlier of (i) the three (3) months following such termination (or such longer or shorter period specified in the Option Agreement), or (ii) the
expiration of the term of the Option as set forth in the Option Agreement. If, after termination, the Optionholder does not exercise his or her Option within the time specified in the Option
Agreement, the Option shall terminate. 

        (g)   Extension of Termination Date.    An Optionholder's Option Agreement may also provide that if the exercise of
the Option following the termination of the Optionholder's Continuous Service (other than upon the Optionholder's death or Disability) would be prohibited at any time solely because the issuance of
shares of Common Stock would violate the registration requirements under the Securities Act or similar requirements of applicable law of another jurisdiction to which the Option is subject, then the
Option shall terminate on the earlier of (i) the expiration of the term of the Option set forth in the Option Agreement, or (ii) the expiration of a period of three (3) months
after the termination of the Optionholder's Continuous Service during which the exercise of the Option would not be in violation of such registration requirements or similar requirements. 

        (h)   Disability of Optionholder.    In the event that an Optionholder's Continuous Service terminates as a result of
the Optionholder's Disability, the Optionholder may exercise his or her Option (to the extent that the Optionholder was entitled to exercise such Option as of the date of termination or as otherwise
permitted by the Company), but only within such period of time ending on the earlier of (i) the twelve (12) months following such termination (or such longer or shorter period specified
in the Option Agreement) or (ii) the expiration of the term of the Option as set forth in the Option Agreement. If, after termination, the Optionholder does not exercise his or her Option
within the time specified herein, the Option shall terminate. 

        (i)    Death of Optionholder.    In the event (i) an Optionholder's Continuous Service terminates as a result
of the Optionholder's death or (ii) the Optionholder dies within the period (if any) specified in the Option Agreement after the termination of the Optionholder's Continuous Service for a
reason other than death, then the Option may be exercised (to the extent the Optionholder was entitled to exercise such Option as of the date of death or as otherwise permitted by the Company) by the
Optionholder's estate, by a person who acquired the right to exercise the Option by bequest or inheritance or by a person designated to exercise the Option upon the Optionholder's death pursuant to
Section 6(d), but only within the period ending on the earlier of (1) the date eighteen (18) moths following the date of death (or such longer or shorter period specified in the
Option Agreement) or (2) the expiration of the term of such Option as set forth in the Option Agreement. If, after death, the Option is not exercised within the time specified herein, the
Option shall terminate. 

        (j)    Early Exercise.    The Option may include a provision whereby the Optionholder may elect at any time before the
Optionholder's Continuous Service terminates to exercise the Option as to any part or all of the shares of Common Stock subject to the Option prior to the full vesting of the Option. Any unvested
shares of Common Stock so purchased may be subject to a repurchase option in favor of the Company or to any other restriction the Board determines to be appropriate. 

7.     PROVISIONS OF STOCK AWARDS OTHER THAN OPTIONS.

        (a)   Stock Bonus Awards.    Each stock bonus agreement shall be in such form and shall contain such terms and
conditions as the Board shall deem appropriate. The terms and conditions of stock bonus agreements may change from time to time, and the terms and conditions of separate stock bonus agreements shall
include (through incorporation of provisions hereof by reference in the agreement or otherwise) the substance of each of the following provisions: 

        (i)    Consideration.    A stock bonus award may be awarded in consideration for past services actually rendered to
the Company or an Affiliate for its benefit. 

A-A-6

 

        (ii)   Vesting.    Shares of Common Stock awarded under the stock bonus agreement may be subject to a share
repurchase option in favor of the Company in accordance with a vesting schedule to be determined by the Board. 

        (iii) Termination of Participant's Continuous Service.    In the event a Participant's Continuous Service
terminates, the Company shall automatically reacquire any or all of the shares of Common Stock held by the Participant which have not vested as of the date of termination under the terms of the stock
bonus agreement. 

        (iv)  Transferability.    Rights to acquire shares of Common Stock under the stock bonus agreement shall be
transferable by the Participant only upon such terms and conditions as are set forth in the stock bonus agreement, as the Board shall determine in its discretion, so long as Common Stock awarded under
the stock bonus agreement remains subject to the terms of the stock bonus agreement. 

        (b)   Restricted Stock Purchase Awards.    Each restricted stock purchase agreement shall be in such form and shall
contain such terms and conditions as the Board shall deem appropriate. The terms and conditions of the restricted stock purchase agreements may change from time to time, and the terms and conditions
of separate restricted stock purchase agreements need not be identical, but each restricted stock purchase agreement shall include (through incorporation of provisions hereof by reference in the
agreement or otherwise) the substance of each of the following provisions: 

        (i)    Purchase Price.    The purchase price under each restricted stock purchase agreement shall be such amount as
the Board shall determine and designate in such restricted stock purchase agreement. 

        (ii)   Consideration.    The purchase price of Common Stock acquired pursuant to the restricted stock purchase
agreement shall be paid either: (i) in cash at the time of purchase; (ii) at the discretion of the Board, according to a deferred payment or other similar arrangement with the
Participant; or (iii) in any other form of legal consideration that may be acceptable to the Board in its discretion; provided, however, that at any time that the Company is incorporated in
Delaware, then payment of the Common Stock's "par value," as defined in the Delaware General Corporation Law, shall not be made by deferred payment. 

        (iii) Vesting.    Shares of Common Stock acquired under the restricted stock purchase agreement may be subject to a
share repurchase option in favor of the Company in accordance with a vesting schedule to be determined by the Board. 

        (iv)  Termination of Participant's Continuous Service.    In the event a Participant's Continuous Service
terminates, the Company may repurchase or otherwise reacquire any or all of the shares of Common Stock held by the Participant which have not vested as of the date of termination under the terms of
the restricted stock purchase agreement. 

        (v)   Transferability.    Rights to acquire shares of Common Stock under the restricted stock purchase agreement
shall be transferable by the Participant only upon such terms and conditions as are set forth in the restricted stock purchase agreement, as the Board shall determine in its discretion, so long as
Common Stock awarded under the restricted stock purchase agreement remains subject to the terms of the restricted stock purchase agreement. 

8.     COVENANTS OF THE COMPANY.

        (a)   Availability of Shares.    During the terms of the Stock Awards, the Company shall keep available at all times
the number of shares of Common Stock required to satisfy such Stock Awards. 

        (b)   Securities Law Compliance.    The Company shall seek to obtain from each regulatory commission or agency having
jurisdiction over the Plan such authority as may be required to grant 

A-A-7

 

Stock
Awards and to issue and sell shares of Common Stock upon exercise of the Stock Awards; provided, however, that this undertaking shall not require the Company to register under the Securities Act
the Plan, any Stock Award or any Common Stock issued or issuable pursuant to any such Stock Award. If, after reasonable efforts, the Company is unable to obtain from any such regulatory commission or
agency the authority which counsel for the Company deems necessary for the lawful issuance and sale of Common Stock under the Plan, the Company shall be relieved from any liability for failure to
grant Stock Awards in compliance with applicable law or to issue and sell Common Stock upon exercise of such Stock Awards unless and until such authority is obtained. 

9.     USE OF PROCEEDS FROM STOCK.

        Proceeds from the sale of Common Stock pursuant to Stock Awards shall constitute general funds of the Company. 

10.   MISCELLANEOUS.

        (a)   Stockholder Rights.    No Participant shall be deemed to be the holder of, or to have any of the rights of a
holder with respect to, any shares of Common Stock subject to such Stock Award unless and until such Participant has satisfied all requirements for exercise of the Stock Award pursuant to its terms. 

        (b)   No Employment or other Service Rights.    Nothing in the Plan or any instrument executed or Stock Award granted
pursuant thereto shall confer upon any Participant any right to continue to serve the Company or an Affiliate in the capacity in effect at the time the Stock Award was granted or shall affect the
right of the Company or an Affiliate to terminate (i) the employment of an Employee with or without notice and with or without cause, (ii) the service of a Consultant pursuant to the
terms of such Consultant's agreement with the Company or an Affiliate or (iii) the service of a Director pursuant to the Bylaws of the Company or an Affiliate, and any applicable provisions of
the corporate law of the state in which the Company or the Affiliate is incorporated, as the case may be. 

        (c)   Investment Assurances.    The Company may require a Participant, as a condition of exercising or acquiring
Common Stock under any Stock Award, (i) to give written assurances satisfactory to the Company as to the Participant's knowledge and experience in financial and business matters and/or to
employ a purchaser representative reasonably satisfactory to the Company who is knowledgeable and experienced in financial and business matters and that he or she is capable of evaluating, alone or
together with the purchaser representative, the merits and risks of exercising the Stock Award; and (ii) to give written assurances satisfactory to the Company stating that the Participant is
acquiring Common Stock subject to the Stock Award for the Participant's own account and not with any present intention of selling or otherwise distributing the Common Stock. The foregoing
requirements, and any assurances given pursuant to such requirements, shall be inoperative if (1) the issuance of the shares of Common Stock upon the exercise or acquisition of Common Stock
under the Stock Award has been registered under a then currently effective registration statement under the Securities Act or (2) as to any particular requirement, a determination is made by
counsel for the Company that such requirement need not be met in the circumstances under the then applicable securities laws. The Company may, upon advice of counsel to the Company, place legends on
stock certificates issued under the Plan as such counsel deems necessary or appropriate in order to comply with applicable securities laws, including, but not limited to, legends restricting the
transfer of the Common Stock. 

        (d)   Withholding Obligations.    To the extent provided by the terms of a Stock Award Agreement, the Participant may
satisfy any federal, state or local tax withholding obligation relating to the exercise or acquisition of Common Stock under a Stock Award by any of the following means (in addition to the Company's
right to withhold from any compensation paid to the Participant by the Company) or by a combination of such means: (i) tendering a cash payment; (ii) authorizing the Company to withhold 

A-A-8

 

shares
of Common Stock from the shares of Common Stock otherwise issuable to the Participant as a result of the exercise or acquisition of Common Stock under the Stock Award, provided, however, that
no shares of Common Stock are withheld with a value exceeding the minimum amount of tax required to be withheld by law; or (iii) delivering to the Company owned and unencumbered shares of
Common Stock. 

11.   ADJUSTMENTS UPON CHANGES IN STOCK.

        (a)   Capitalization Adjustments.    If any change is made in the Common Stock subject to the Plan, or subject to any
Stock Award, without the receipt of consideration by the Company (through merger, consolidation, reorganization, recapitalization, reincorporation, stock dividend, dividend in property other than
cash, stock split, liquidating dividend, combination of shares, exchange of shares, change in corporate structure or other transaction not involving the receipt of consideration by the Company), the
Plan will be appropriately adjusted in the type, class(es) and maximum number of securities subject to the Plan pursuant to Section 4(a), and the outstanding Stock Awards will be appropriately
adjusted in the type, class(es) and number of securities and price per share of securities subject to such outstanding Stock Awards. The Board shall make such adjustments, and its determination shall
be final, binding and conclusive. (The conversion of any convertible securities of the Company shall not be treated as a transaction "without receipt of consideration" by the Company.) 

        (b)   Dissolution or Liquidation.    In the event of a dissolution or liquidation of the Company, then all
outstanding Stock Awards shall terminate immediately prior to such event. 

        (c)   Asset Sale, Merger, Consolidation or Reverse Merger.    In the event of (i) a sale, exchange, lease or
other disposition of all or substantially all of the assets of the Company, (ii) a merger or consolidation in which the Company is not the surviving corporation or (iii) a reverse merger
in which the Company is the surviving corporation but the shares of Common Stock outstanding immediately preceding the merger are converted by virtue of the merger into other property, whether in the
form of securities, cash or otherwise (individually, a "Corporate Transaction"), then any surviving corporation or acquiring corporation shall assume or continue any Stock Awards outstanding under the
Plan or shall substitute similar stock awards (including an award to acquire the same consideration paid to the stockholders in the Corporate Transaction) for those outstanding under the Plan. In the
event any surviving corporation or acquiring corporation refuses to assume or continue such Stock Awards or to substitute similar stock awards for those outstanding under the Plan, then with respect
to Stock Awards held by Participants whose Continuous Service has not terminated, the vesting of such Stock Awards (and, if applicable, the time during which such Stock Awards may be exercised) shall
be accelerated in full, and the Stock Awards shall terminate if not exercised (if applicable) at or prior to the Corporate Transaction. With respect to any other Stock Awards outstanding under the
Plan, such Stock Awards shall terminate if not exercised (if applicable) prior to the Corporate Transaction. 

12.   AMENDMENT OF THE PLAN AND STOCK AWARDS.

        (a)   Amendment of Plan.    The Board at any time, and from time to time, may amend the Plan. However, except as
provided in Section 11 relating to adjustments upon changes in stock, no amendment shall be effective unless approved by the stockholders of the Company to the extent stockholder approval is
necessary for the Plan to satisfy any Nasdaq or securities exchange listing requirements. The Board may in its sole discretion submit such amendment to the Plan for stockholder approval. 

        (b)   No Impairment of Rights.    Rights under any Stock Award granted before amendment of the Plan shall not be
materially impaired by any amendment of the Plan unless (i) the Company requests the consent of the Participant and (ii) the Participant consents in writing. 

A-A-9

 

        (c)   Amendment of Stock Awards.    The Board at any time, and from time to time, may amend the terms of any one or
more Stock Awards; provided, however, that the rights under any Stock Award shall not be materially impaired by any such amendment unless (i) the Company requests the consent of the Participant
and (ii) the Participant consents in writing. 

13.   TERMINATION OR SUSPENSION OF THE PLAN.

        (a)   Plan Term.    The Board may suspend or terminate the Plan at any time. No Stock Awards may be granted under the
Plan while the Plan is suspended or after it is terminated. 

        (b)   No Impairment of Rights.    Suspension or termination of the Plan shall not impair rights and obligations under
any Stock Award granted while the Plan is in effect except with the written consent of the Participant. 

14.   EFFECTIVE DATE OF PLAN.

        The Plan shall become effective immediately upon its adoption by the Board. 

15.   CHOICE OF LAW.

        The law of the State of California shall govern all questions concerning the construction, validity and interpretation of this Plan, without regard to such
state's conflict of laws rules. 

A-A-10

QuickLinks

Exhibit 10.21

RIGEL PHARMACEUTICALS, INC. 2000 EQUITY INCENTIVE PLANExhibit
4.24

 

 

 

 

 

 

 

 

REGISTRATION
RIGHTS AGREEMENT

 

dated as of [  ], 2008

 

among

 

FOAMEX
INTERNATIONAL INC.

 

and

 

THE SIGNIFICANT
EQUITYHOLDERS NAMED HEREIN

 

 

 

 

 

 

 

 

 

TABLE OF CONTENTS

 

	
  SECTION 1. DEFINITIONS

  	
  1

  
	
   

  	
   

  
	
  1.1.

  	
  Defined Terms

  	
  1

  
	
   

  	
   

  	
   

  
	
  1.2.

  	
  General Interpretive Principles

  	
  4

  
	
   

  	
   

  
	
  SECTION 2. REGISTRATION RIGHTS

  	
  4

  
	
   

  	
   

  
	
  2.1.

  	
  Shelf Registration

  	
  4

  
	
   

  	
   

  	
   

  
	
  2.2.

  	
  Demand Registrations

  	
  6

  
	
   

  	
   

  	
   

  
	
  2.3.

  	
  Incidental Registrations

  	
  9

  
	
   

  	
   

  	
   

  
	
  2.4.

  	
  Black-out Periods

  	
  10

  
	
   

  	
   

  	
   

  
	
  2.5.

  	
  Registration Procedures

  	
  11

  
	
   

  	
   

  	
   

  
	
  2.6.

  	
  Underwritten Offerings

  	
  16

  
	
   

  	
   

  	
   

  
	
  2.7.

  	
  No Inconsistent Agreements; Additional Rights

  	
  17

  
	
   

  	
   

  	
   

  
	
  2.8.

  	
  Registration Expenses

  	
  17

  
	
   

  	
   

  	
   

  
	
  2.9.

  	
  Indemnification

  	
  18

  
	
   

  	
   

  	
   

  
	
  2.10.

  	
  Rules 144 and 144A

  	
  20

  
	
   

  	
   

  
	
  SECTION 3. MISCELLANEOUS

  	
  21

  
	
   

  	
   

  
	
  3.1.

  	
  Existing Registration Statements

  	
  21

  
	
   

  	
   

  	
   

  
	
  3.2.

  	
  Term

  	
  21

  
	
   

  	
   

  	
   

  
	
  3.3.

  	
  Injunctive Relief

  	
  21

  
	
   

  	
   

  	
   

  
	
  3.4.

  	
  Attorneys’ Fees

  	
  21

  
	
   

  	
   

  	
   

  
	
  3.5.

  	
  Notices

  	
  21

  
	
   

  	
   

  	
   

  
	
  3.6.

  	
  Successors, Assigns and Transferees

  	
  23

  
	
   

  	
   

  	
   

  
	
  3.7.

  	
  Governing Law; Service of Process; Consent to
  Jurisdiction

  	
  23

  
	
   

  	
   

  	
   

  
	
  3.8.

  	
  Headings

  	
  24

  
	
   

  	
   

  	
   

  
	
  3.9.

  	
  Severability

  	
  24

  
	
   

  	
   

  	
   

  
	
  3.10.

  	
  Amendment; Waiver

  	
  24

  
	
   

  	
   

  	
   

  
	
  3.11.

  	
  Counterparts

  	
  25

  

 

 

 

 

 

 

 

REGISTRATION RIGHTS AGREEMENT

 

                    This REGISTRATION RIGHTS AGREEMENT (the “Agreement”) is dated as of [  ], 2008, by and among Foamex International Inc., a Delaware corporation (the “Issuer”), and D. E. Shaw Laminar Portfolios, L.L.C. (“D. E. Shaw”), Sigma Capital Associates, LLC (“Sigma”), CGDO, LLC (as agent on behalf of Chilton Global Distressed Opportunities Master Fund, L.P.) and Q Funding III, L.P. (each, a “Significant Equityholder”).
 
                    WHEREAS, the Issuer and the Significant Equityholders, severally and not jointly, have entered into an Equity Commitment Agreement, dated April 1, 2008 (the “Equity Commitment Agreement”), pursuant to which the Issuer has agreed to use its reasonable best efforts to consummate an offering to the Issuer’s stockholders as of the record date of rights to purchase shares of Common Stock (the “Rights Offering”) and an offering of shares of Common Stock to the lenders under its second lien term loan facility (the “Second Lien Term Loan Offering”);
 
                    WHEREAS, the Issuer has entered into Put Option Agreements, dated as of April 1, 2008 (the “Put Option Agreements”), with each of the Significant Equityholders, pursuant to which each of the Significant Equityholders has granted the Issuer an option to require the Significant Equityholder to purchase shares of Common Stock to the extent the Significant Equityholder did not exercise its Rights in the Rights Offering or participate in the Second Lien Term Loan Offering, whether or not such offerings are consummated;
 
                    WHEREAS, in connection with and pursuant to the Equity Commitment Agreement, the Issuer has agreed with the Significant Equityholders to provide certain rights as set forth herein.
 
                    NOW, THEREFORE, in consideration of the foregoing and the mutual promises, covenants and agreements of the parties hereto, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:
 

SECTION 1.   DEFINITIONS

 

1.1.          Defined Terms.  As used in this Agreement, the following
terms shall have the following meanings:

 

“Adverse
Disclosure” means public disclosure of material non-public information,
which disclosure in the good faith judgment of the Board of Directors after
consultation with counsel to the Issuer (i) would be required to be made
in any Registration Statement so that such Registration Statement would not be
materially misleading, (ii) would not be required to be made at such time
but for the filing of such Registration Statement and (iii) would have a
material adverse effect on the Issuer or its business or on the Issuer’s
ability to effect a material acquisition, disposition or financing.

 

“Agreement”
has the meaning set forth in the preamble hereto.

 

 

 

 

 

“Board of Directors” means the Board of Directors of the Issuer.

 

“Common Stock” means the common stock, par value $0.01, of the
Issuer.

 

“Demand
Registration” has the meaning set forth in Section 2.2(a).

 

“Equity
Commitment Agreement” has the meaning set forth in the preamble hereto.

 

“Equity
Cure Letters” means the letters entered into between the Issuer and each of
D. E. Shaw, Sigma and Goldman, Sachs & Co. on February 13, 2008
in connection with the potential cure of certain defaults under the credit
agreements of the Issuer.

 

“Exchange Act” means the Securities Exchange Act of 1934, as
amended, and any successor thereto, and any rules and regulations
promulgated thereunder, all as the same shall be in effect from time to time.

 

“FINRA”
means the Financial Industry Regulatory Authority.

 

“Free Writing Prospectus” means a free writing prospectus, as
defined in Rule 405 under the Securities Act.

 

“holder” or “holders” means any holder or holders of
Registrable Securities who is a party hereto or who otherwise agrees in writing
to be bound by the provisions of this Agreement pursuant to Section 3.6.

 

“Incidental Registration” has the meaning set forth in Section 2.3(a).

 

“Inspector” has the meaning set forth in Section 2.5(a)(xix).

 

“Issuer” has the meaning set forth in the preamble hereto and
shall include the Issuer’s successors by merger, acquisition, reorganization or
otherwise.

 

“Issuer Free Writing Prospectus” means an issuer free writing
prospectus, as defined in Rule 433 under the Securities Act, relating to
an offer of the Registrable Securities.

 

“Significant
Equityholder” has the meaning set forth in the preamble hereto.

 

“Loss”
has the meaning set forth in Section 2.9(a).

 

“Person” means any individual, firm, limited liability company
or partnership, joint venture, corporation, joint stock company, trust or
unincorporated organization, incorporated or unincorporated association,
government (or any department, agency or political subdivision thereof) or
other entity of any kind.

 

“Prospectus” means the prospectus included in any Registration
Statement, all amendments and supplements to such prospectus and all material
incorporated by reference in such prospectus.

 

 

 

 

 

2

 

 

“Put Option Agreements” has the meaning set forth in the
preamble hereto.

 

“Records” has the meaning set forth in Section 2.5(a)(xix).

 

“Registrable Securities” means (i) the shares of Common
Stock, if any, acquired by the Significant Equityholders in connection with the
Rights Offering; (ii) the shares of Common Stock, if any, acquired by the
Significant Equityholders in connection with the Second Lien Term Loan
Offering, (iii) the shares of Common Stock, if any, acquired by the
Significant Equityholders pursuant to the Put Option Agreements, including,
without limitation, the shares of Common Stock, if any, issued in payment of
the Put Option Premium (as defined in the Put Option Agreements); (iv) any
shares of Common Stock acquired by D. E. Shaw or Sigma pursuant to the
conversion of shares of Series D Preferred Stock, par value $0.01 per
share, of the Issuer; (v) any other shares of Common Stock held by the
Significant Equityholders; and (vi) any securities that may be issued or
distributed or be issuable to the Significant Equityholders in respect of the
foregoing by way of stock dividend, stock split or other distribution, merger,
consolidation, exchange offer, recapitalization or reclassification or similar
transaction or exercise or conversion of any of the foregoing; provided,
however, that any of the foregoing securities listed in the preceding
clauses (i) through (vi) shall cease to be “Registrable Securities”
to the extent (i) a Registration Statement with respect to their sale has
become effective under the Securities Act and they have been disposed of
pursuant to such Registration Statement, (ii) they have been distributed
pursuant to Rule 144 (or any similar provision then in force) under the
Securities Act, (iii) they may be publicly resold (without volume or
method of sale restrictions) without registration under the Securities Act or (iv) they
have ceased to be outstanding.  For
purposes of this Agreement, a “class” of Registrable Securities shall mean all
Securities with the same terms and a “percentage” (or a “majority”) of the
Registrable Securities (or, where applicable, of any other securities) shall be
determined (x) based on the number of shares of such securities, in the
case of Registrable Securities which are equity securities, and (y) based
on the principal amount of such securities, in the case of Registrable
Securities which are debt securities.

 

“registration” means a registration of the Issuer’s securities
for sale to the public under a Registration Statement.

 

“Registration Statement” means any registration statement of the
Issuer filed with, or to be filed with, the SEC under the rules and
regulations promulgated under the Securities Act, including the Prospectus,
amendments and supplements to such registration statement, including post-effective
amendments, and all exhibits and all material incorporated by reference in such
registration statement.

 

“Rights Offering” has the meaning set forth in the preamble
hereto.

 

“SEC”
means the Securities and Exchange Commission.

 

“Second Lien Term Loan Offering” has the meaning set forth in
the preamble hereto.

 

 

 

 

3

 

 

“Securities Act” means the Securities Act of 1933, as amended,
and any successor thereto, and any rules and regulations promulgated
thereunder, all as the same shall be in effect from time to time.

 

“Shelf Registration” means a registration effected pursuant to Section 2.1.

 

“Shelf Registration Statement” means a Registration Statement of
the Issuer filed with the SEC on Form S-3 or Form S-3ASR (or any
successor form or other appropriate form under the Securities Act) for an
offering to be made on a continuous or delayed basis pursuant to Rule 415
under the Act (or any similar rule that may be adopted by the SEC)
covering the Registrable Securities.

 

“Underwritten Offering” means a registration in which securities
of the Issuer are sold to an underwriter or underwriters on a firm commitment
basis for reoffering to the public.

 

“Valid Business Reason” has the meaning set forth in Section 2.2(e).

 

1.2.          General
Interpretive Principles.  Whenever
used in this Agreement, except as otherwise expressly provided or unless the
context otherwise requires, any noun or pronoun shall be deemed to include the
plural as well as the singular and to cover all genders.  The name assigned this Agreement and the
section captions used herein are for convenience of reference only and shall
not be construed to affect the meaning, construction or effect hereof.  Unless otherwise specified, the terms “hereof,”
“herein,” “hereunder” and similar terms refer to this Agreement as a whole
(including the exhibits, schedules and disclosure statements hereto), and
references herein to Sections refer to Sections of this Agreement.

 

SECTION 2.   REGISTRATION
RIGHTS

 

2.1.          Shelf Registration.

 

(a)           Filing.  Subject to Section 2.1(c), if the Issuer
becomes eligible to file a registration statement on Form S-3 or Form S-3ASR
(or any successor form) in respect of any class of Registrable Securities, it
shall promptly notify the holders of such eligibility, and within 60 days
following the request of any holder or holders holding at least 25% of any such
class, the Issuer shall file with the SEC a Shelf Registration Statement
relating to the offer and sale of any Registrable Securities held by the
holders thereof from time to time in accordance with the methods of
distribution elected by such holders and shall use its reasonable best efforts
to cause such Shelf Registration Statement to become effective under the
Securities Act.

 

(b)           Continued
Effectiveness.  Subject to Section 2.1(c),
the Issuer shall use its reasonable best efforts to keep the Shelf Registration
Statement continuously effective in order to permit the Prospectus forming a
part thereof to be usable by the holders during the term of this
Agreement.  The Issuer shall not be deemed to have used its reasonable best efforts
to keep the Shelf Registration Statement effective if the Issuer voluntarily
takes any action or omits to take any action that would result in the inability
of any holder of Registrable Securities covered by such Registration Statement
to be able to offer and sell any such Registrable Securities during the term of
this Agreement, unless such action or omission is required by applicable law.

 

 

 

 

 

4

 

 

(c)           Suspension of
Registration.  If the filing, initial
effectiveness or continued use of the Shelf Registration Statement at any time
would require the Issuer to make an Adverse Disclosure or, if in the good faith
judgment of the Board of Directors, there exists a Valid Business Reason, the
Issuer may, upon giving prompt written notice of such action to the holders,
delay the filing or initial effectiveness of, or suspend use of, the Shelf
Registration Statement; provided, however, that the Issuer shall
not be permitted to do so (A) more than one time during any three-month
period, (B) for a period exceeding 45 days on any one occasion or (C) for
a period exceeding 90 days in any 12-month period.  In the event the Issuer exercises its rights
under the preceding sentence, the holders agree to suspend, immediately upon
their receipt of the notice referred to above, their use of the Prospectus
relating to the Shelf Registration and any Issuer Free Writing Prospectuses in
connection with any sale or offer to sell Registrable Securities.  The Issuer shall immediately notify the
holders upon the expiration of any period during which it exercised its rights
under this Section 2.1(c).  The
Issuer represents that it currently has no knowledge of any circumstance that
would reasonably be expected to cause the Issuer to exercise its rights under
this Section 2.1(c).

 

(d)           Underwritten
Offering.  If the holders of not less
than a majority of any class of Registrable Securities included in any offering
pursuant to the Shelf Registration Statement so elect, such offering shall be
in the form of an Underwritten Offering and the Issuer, if necessary, shall use
its reasonable best efforts to amend or supplement the Shelf Registration
Statement for such purpose.  The Issuer,
after consulting with the holders of a majority of the class of Registrable
Securities to be included in such Underwritten Offering, shall have the right
to select the managing underwriter or underwriters for the offering.  If the managing underwriter or underwriters
of any such proposed Underwritten Offering informs the holders of Registrable
Securities of any class sought to be included in such registration in writing
that, in its or their opinion, the total amount or kind of securities which
such holders and any other Persons intend to include in such offering exceeds
the number or amount which can be sold in such offering without being likely to
have a significant adverse effect on the price, timing or distribution of the class
or classes of the securities offered or the market for the class or classes of
securities offered, then the securities of each class to be included in such
registration shall be allocated as follows:

 

(i)            first, pro  rata
among the holders which have requested participation in such Underwritten
Offering (based, for each such holder, on the percentage derived by dividing (x) the
number or amount of Registrable Securities of such class which such holder has
requested to include in such Underwritten Offering by (y) the aggregate
number or amount of Registrable Securities of such class which all such holders
have requested to include);

 

(ii)           second, and only if all the
securities referenced in clause (i) have been included, any other
securities of the Issuer requested by the holders thereof to included in such
registration that, in the opinion of such underwriter or underwriters, can be
sold without having such adverse effect shall be included therein, with such
number to be allocated pro  rata among such holders (based, for
each such holder, on the percentage derived by dividing (x) the number or
amount of such securities of such class which such holder has requested to
include in such registration by (y) the aggregate number or amount of
securities of such class which all such holders have requested to include); and

 

 

 

 

 

5

 

 

(iii)          third, and only if all of the
Registrable Securities referenced in clauses (i) and (ii) have been
included and in the opinion of such underwriter or underwriters such securities
can be sold without having such adverse effect, securities offered by the
Issuer for its own account.

 

2.2.          Demand Registrations.

 

(a)           Demand by Holders.  (i)  At any time the holders of not less
than 25% percent of any class of the Registrable Securities may make a written
request to the Issuer for registration of all or part of the Registrable
Securities held by such holders, provided that at least 25% of such class shall
be so registered.  Any such requested registration
shall hereinafter be referred to as a “Demand Registration.”  Each request for a Demand Registration shall
specify the aggregate amount of Registrable Securities to be registered and the
intended methods of disposition thereof.

 

(ii)  Within ten days following receipt of any request for a
Demand Registration, the Issuer shall deliver written notice of such request to
all other holders of Registrable Securities of the class or classes to be
registered.  Thereafter, the Issuer shall
include in such Demand Registration any additional Registrable Securities of
each such class which the holder or holders thereof have requested in writing
be included in such Demand Registration, provided that all requests therefor
have been received by the Issuer within ten days of the Issuer’s having sent
the applicable notice to such holder or holders.  The failure of any such holder to respond
within such ten-day period shall be deemed to be a waiver of such holder’s
rights under Section 2.2(a)(ii) with respect to such Demand
Registration.  All such requests shall
specify the aggregate amount and class of Registrable Securities to be
registered and the intended method of distribution of the same.

 

(iii)  As promptly as practicable (and, in any event, within 60
days) following receipt of a request for a Demand Registration, the Issuer
shall file a Registration Statement relating to such Demand Registration and
shall use its reasonable best efforts to cause such Registration Statement to
become effective under the Securities Act.

 

(b)           Limitation on
Demand Registrations.  In no event
shall the Issuer be required to effect more than two Demand Registrations.

 

(c)           Demand Withdrawal.  A holder may withdraw its Registrable
Securities from a Demand Registration at any time.  If all such holders do so, the Issuer shall
cease all efforts to secure registration and such registration nonetheless
shall be deemed a Demand Registration for purposes of Section 2.2(b) unless
(i) the withdrawal is based on the reasonable determination of the holders
who requested such registration that there has been, since the date of such
request, a material adverse change in the business or prospects of the Issuer
or (ii) the holders who requested such registration shall have paid or
reimbursed the Issuer for all of the reasonable out-of-pocket fees and expenses
incurred by the Issuer in connection with the withdrawn registration.

 

(d)           Effective
Registration.  The Issuer shall be
deemed to have effected a Demand Registration if the applicable Registration
Statement becomes effective and remains 

 

 

 

 

6

 

 

effective for not less than 180 days (or such shorter
period as will terminate when all Registrable Securities covered by such
Registration Statement have been sold or withdrawn), or, if such Registration
Statement relates to an Underwritten Offering, such longer period as, in the
opinion of counsel for the underwriter or underwriters, is required by law for
the delivery of a Prospectus in connection with the sale of Registrable
Securities by an underwriter or dealer. 
No Demand Registration shall be deemed to have been effected if an
Underwritten Offering is contemplated by such Demand Registration and the
conditions to closing specified in the applicable underwriting agreement are
not satisfied by reason of a wrongful act, misrepresentation or breach of such
underwriting agreement or this Agreement by the Issuer.

 

(e)           Suspension of
Registration.  If the filing, initial
effectiveness or continued use of a Registration Statement in respect of a
Demand Registration at any time would require the Issuer to make an Adverse
Disclosure or, if in the good faith judgment of the Board of Directors, it
would materially interfere with any material financing, acquisition, corporate
reorganization or merger or other material transaction involving the Issuer (a “Valid
Business Reason”), the Issuer may, upon giving prompt written notice of
such action to the holders, delay the  filing or  initial effectiveness of, or  suspend
use of, the such Registration Statement; provided, however, that
the Issuer shall not be permitted to do so (A) more than one time during
any three-month period, (B) for a period exceeding 45 days on any one
occasion or (C) for a period exceeding 90 days in any 12-month
period.  In the event the Issuer
exercises its rights under the preceding sentence, the holders agree to
suspend, immediately upon their receipt of the notice referred to above, their
use of the Prospectus relating to the Demand Registration and any Issuer Free
Writing Prospectus in connection with any sale or offer to sell Registrable
Securities.  The Issuer shall immediately
notify the holders of the expiration of any period during which it exercised
its rights under this Section 2.2(e). 
The Issuer represents that it currently has no knowledge of any
circumstance that would reasonably be expected to cause the Issuer to exercise
its rights under this Section 2.2(e).

 

(f)            Underwritten
Offering.  If the holders of not less
than a majority of the Registrable Securities of any class which are included
in any offering pursuant to a Demand Registration so elect, the Issuer shall
use its reasonable best efforts to cause such offering to be in the form of an
Underwritten Offering.  The Issuer, after
consulting with the holders of a majority of the class of Registrable
Securities to be included in such Underwritten Offering, shall have the right
to select the managing underwriter or underwriters for the offering.

 

(g)           Priority of
Securities Registered Pursuant to Demand Registrations.  If the managing underwriter or underwriters
of a proposed Underwritten Offering of a class of Registrable Securities
included in a Demand Registration (or, in the case of a Demand Registration not
being underwritten, the holders of a majority of a class of Registrable
Securities included in such Registration Statement), inform the holders of such
Registrable Securities in writing that, in its or their opinion, the number or
amount of securities of such class requested to be included in such Demand
Registration exceeds the number or amount which can be sold in such offering
without being likely to have a significant adverse effect on the price, timing
or distribution of the class of securities offered or the market for the class of
securities offered, the number or amount of Registrable Securities of such
class that can be included without having such an adverse effect shall be
allocated:

 

 

 

7

 

 

(i)            first, pro  rata
among the holders which have requested participation in the Demand Registration
(based, for each such holder, on the percentage derived by dividing (x) the
number or amount of Registrable Securities of such class which such holder has
requested to include in such Demand Registration by (y) the aggregate
number or amount of Registrable Securities of such class which all such holders
have requested to include);

 

(ii)           second, and only if all the
securities referenced in clause (i) have been included, any other
securities of the Issuer requested by the holders thereof to included in such
registration that, in the opinion of such underwriter or underwriters, can be
sold without having such adverse effect shall be included therein, with such
number to be allocated pro  rata among such holders (based, for
each such holder, on the percentage derived by dividing (x) the number or
amount of such securities of such class which such holder has requested to
include in such registration by (y) the aggregate number or amount of
securities of such class which all such holders have requested to include); and

 

(iii)          third, and only if all of the
Registrable Securities referenced in clauses (i) and (ii) have been
included and in the opinion of such underwriter or underwriters such securities
can be sold without having such adverse effect securities offered by the Issuer
for its own account.

 

To the extent that any Registrable
Securities requested to be registered are excluded pursuant to the foregoing,
the holders thereof shall have the right to one additional Demand Registration
under this Section 2.2.

 

                                (h)           Registration
Statement Form.  Registrations under
this Section 2.2 shall be on such appropriate registration form of the SEC
(i) as shall be selected by the Issuer and as shall be reasonably acceptable
to the holders of a majority of each class of Registrable Securities requesting
participation in the Demand Registration and (ii) as shall permit the
disposition of the Registrable Securities in accordance with the intended
method or methods of disposition specified in the applicable holders’ requests
for such registration.  Notwithstanding the
foregoing, if, pursuant to a Demand Registration, (x) the Issuer proposes
to effect registration by filing a Registration Statement on Form S-3 or Form S-3ASR
(or any successor or similar short-form registration statement), (y) such
registration is in connection with an Underwritten Offering and (z) the
managing underwriter or underwriters shall advise the Issuer in writing that,
in its or their opinion, the use of another form of registration statement (or
the inclusion, rather than the incorporation by reference, of information in
the Prospectus related to a Registration Statement on Form S-3 or Form S-3ASR
(or other short-form registration statement)) is of material importance to the
success of such proposed offering, then such registration shall be effected on
such other form (or such information shall be so included in such Prospectus); provided,
however, that the Issuer shall not be required to use any form that it
reasonably believes, based on the advice of legal counsel, that it is not
eligible to use and that no Demand Registration shall be effected using a Form S-4
or a Form S-8 or any successor form thereto.

 

 

 

 

 

8

 

2.3.                              Incidental Registrations.

 

(a)                                  Participation.  (i) 
If the Issuer at any time proposes to file a Registration Statement with
respect to any offering of its securities for its own account or for the
account of any holders of its securities (other than (A) a registration
under Section 2.1 or Section 2.2 hereof, (B) a registration on Form S-4
or S-8 or any successor form to such forms or (C) a registration of
securities solely relating to an offering and sale to employees or directors of
the Issuer pursuant to any employee stock plan or other employee benefit plan
arrangement), then, as soon as practicable (but in no event less than 20 days
prior to the proposed date of filing such Registration Statement), the Issuer
shall give written notice of such proposed filing to all holders of Registrable
Securities that are equity securities (in the case of a sale of equity
securities, including securities convertible into equity securities) or of
Registrable Securities that are debt securities (in the case of a sale of debt
securities), and such notice shall offer the holders of such Registrable
Securities the opportunity to register such number or amount of Registrable
Securities as each such holder may request in writing (an “Incidental
Registration”).  Subject to Section 2.3(b),
the Issuer shall include in such Registration Statement all such Registrable
Securities which are requested to be included therein within 10 days after the
receipt by such holder of any such notice. 
The failure of any such holder to respond within such ten-day period
shall be deemed to be a waiver of such holder’s rights under this Section 2.3(a) with
respect to such Incidental Registration. 
If at any time after giving written notice of its intention to register
any securities and prior to the effective date of the Registration Statement
filed in connection with such registration, the Issuer shall determine for any
reason not to register or to delay registration of such securities, the Issuer
may, at its election, give written notice of such determination to each holder
of Registrable Securities and, (x) in the case of a determination not to
register, shall be relieved of its obligation to register any Registrable
Securities in connection with such registration, and (y) in the case of a
determination to delay registering, shall be permitted to delay registering any
Registrable Securities for the same period as the delay in registering such
other securities.

 

(ii)                                  If the offering pursuant to an Incidental
Registration is to be an Underwritten Offering, then each holder making a
request for its Registrable Securities to be included therein must, and the
Issuer shall use its reasonable best efforts to make such arrangements with the
underwriters so that each such holder may, participate in such Underwritten
Offering on the same terms as the Issuer and other Persons selling securities
in such Underwritten Offering.  If the
offering pursuant to such registration is to be on any other basis, then each
holder making a request for an Incidental Registration pursuant to this Section 2.3(a) must
participate in such offering on such basis. 
In connection with any Incidental Registration under Section 2.3
that is an Underwritten Offering, the Issuer shall not be required to include
any Registrable Securities in such Underwritten Offering unless the
participating holders thereof accept the terms of the Underwritten Offering
provided in Section 2.6(a), and then only in such quantity as set forth in
Section 2.3(b).

 

(iii)                               Each holder of Registrable Securities
shall be permitted to withdraw, by written notice to the Issuer, all or part of
such holder’s Registrable Securities from an Incidental Registration at any
time; provided, however, that, except in the case of a withdrawal
pursuant to Section 2.6(b), the Issuer shall be entitled to reimbursement
from the holder of such withdrawn 

 

 

 

 

9

 

 

Registrable Securities for any SEC registration fees
incurred by the Issuer in connection with the registration of such Registrable
Securities.

 

(b)                                 Priority of Incidental Registration. 
If the managing underwriter or underwriters of any proposed Underwritten
Offering of a class of securities included in an Incidental Registration (or in
the case of an Incidental Registration not being underwritten, the Issuer)
informs the holders of Registrable Securities of any class sought to be
included in such registration in writing that, in its or their opinion, the
total amount or kind of securities which such holders and any other Persons
intend to include in such offering exceeds the number or amount which can be
sold in such offering without being likely to have a significant adverse effect
on the price, timing or distribution of the class or classes of the securities
offered or the market for the class or classes of securities offered, then the
securities of each class to be included in such registration shall be allocated
as follows:

 

(i)                                     first, 100% of the securities that the Issuer or (subject
to Section 2.7) any Person (other than a holder of Registrable Securities)
exercising a contractual right to demand registration has proposed to sell
shall be included therein;

 

(ii)                                  second, and only if all the securities referenced in clause (i) have
been included, the number or amount of Registrable Securities of such class
that, in the opinion of such underwriter or underwriters (or in the case of an
Incidental Registration not being underwritten, the Issuer), can be sold
without having such adverse effect shall be included therein, with such number
or amount to be allocated pro  rata among the holders which have
requested participation in the Incidental Registration (based, for each such
holder, on the percentage derived by dividing (x) the number or amount of
Registrable Securities of such class which such holder has requested to include
in such Incidental Registration by (y) the aggregate number or amount of
Registrable Securities of such class which all such holders have requested to
include); and

 

(iii)                               third, and only if all of the Registrable Securities
referenced in clauses (i) and (ii) have been included, any other
securities eligible for inclusion in such registration shall be included
therein.

 

2.4.                              Black-out Periods.

 

(a)                                  Black-out Periods for Holders. 
In the event of a registration by the Issuer involving the offering and
sale by the Issuer of equity securities or securities convertible into or
exchangeable for its equity securities, the holders of Registrable Securities
agree, if requested by the Issuer (or, in the case of an Underwritten Offering,
by the managing underwriter or underwriters), not to effect any public sale or
distribution of any securities (except, in each case, as part of the applicable
registration, if permitted) which securities are the same as or similar to those
being registered in connection with such registration, or which are convertible
into or exchangeable or exercisable for such securities, and not to offer to
sell, contract to sell (including, without limitation, any short sale), grant
any option to purchase or enter into any 

 

 

 

 

10

 

 

hedging or similar transaction with the same economic
effect as a public sale or distribution of any such securities, during the
period beginning seven days before, and ending 90 days (or such lesser period
as may be permitted by the Issuer or such managing underwriter or underwriters)
after, the effective date of the Registration Statement filed in connection
with such registration, to the extent such holders are timely notified in
writing by the Issuer or the managing underwriter or underwriters; provided,
however, that nothing in this Section 2.4(a) shall
prohibit any sale of, or other transaction relating to, Registrable
Securities pursuant to Rule 144 under the Securities Act (or any similar
provision then in force).

 

(b)                                 Black-out Period for the Issuer and
Others.  (i) In
the case of a registration of a class of Registrable Securities pursuant to Section 2.1
or 2.2 involving the offering and sale of equity securities or securities
convertible into or exchangeable for equity securities, the Issuer agrees, if
requested by the holders of a majority of such class of Registrable Securities
to be sold pursuant to such registration (or, in the case of an Underwritten
Offering, by the managing underwriter or underwriters in such Underwritten
Offering), not to effect (or register
for sale) any public sale or distribution of any securities which are
the same as or similar to those being registered, or which are convertible into
or exchangeable or exercisable for such securities, and not to offer to sell,
contract to sell (including, without limitation, any short sale), grant any
option to purchase or enter into any hedging or similar transaction with the
same economic effect as a public sale or distribution of any such securities,
during the period beginning seven days before, and ending 90 days (or such
lesser period as may be permitted by such holders or such underwriter or
underwriters) after, the effective date of the Registration Statement filed in
connection with such registration (or, in the case of an Underwritten Offering
under the Shelf Registration, the date of the closing under the underwriting
agreement in connection therewith), to the extent the Issuer is timely notified
in writing by a holder of Registrable Securities covered by such Registration
Statement or the managing underwriter or underwriters.  Notwithstanding the foregoing, the Issuer may
effect a public sale or distribution of securities of the type described above
and during the periods described above if the same (A) is made pursuant to
registrations on Forms S-4 or S-8 or any successor form to such forms or (B) as
part of any registration of securities for offering and sale to employees or
directors of the Issuer pursuant to any employee stock plan or other employee
benefit plan arrangement.

 

(ii)                                  Subject to Section 2.7,
if after the date hereof the Issuer grants any Person (other than a holder of
Registrable Securities) any rights to demand or participate in a registration,
the Issuer agrees that the agreement with respect thereto shall include such
Person’s agreement not to effect any public sale or distribution of the
securities subject to such agreement (other than securities purchased in a
public offering), or securities that are convertible into or exchangeable or
exercisable for such securities, and not to offer to sell, contract to sell
(including, without limitation, any short sale), grant any option to purchase
or enter into any hedging or similar transaction with the same economic effect
as a public sale or distribution of any such securities, during any period referred to in this Section 2.4(b).

 

2.5.                              Registration Procedures.

 

(a)                                  In connection with the Issuer’s
registration obligations in this Agreement, the Issuer will, subject to the
limitations set forth herein, use its reasonable best efforts to effect any
such registration so as to permit the sale of the applicable Registrable
Securities in 

 

 

 

11

 

 

accordance with the intended method or methods of
distribution thereof as expeditiously as reasonably practicable, and in
connection therewith the Issuer will:

 

(i)                                     before filing a Registration Statement,
Prospectus or any Issuer Free Writing Prospectus, or any amendments or
supplements thereto and in connection therewith, furnish to the underwriter or
underwriters, if any, and to holders of a majority of each class of Registrable
Securities covered by such Registration Statement, copies of all documents prepared
to be filed, which documents will be subject to the review of such underwriters
and such holders and their respective counsel and, except in the case of a
registration under Section 2.3, not file any Registration Statement or
Prospectus or amendments or supplements thereto to which the holders of a
majority of the class of Registrable Securities covered by the same or the
underwriter or underwriters, if any, shall reasonably object;

 

(ii)                                  prepare and file with the SEC such
amendments or supplements to the applicable Registration Statement, Prospectus
or any Issuer Free Writing Prospectus as may be (A) reasonably requested
by any participating holder (to the extent such request relates to information
relating to such holder), (B) necessary to keep such registration
effective for the period of time required by this Agreement or (C) reasonably
requested by the holders of a majority of any class of the participating
Registrable Securities;

 

(iii)                               notify the selling holders of Registrable
Securities and the managing underwriter or underwriters, if any, and (if
requested) confirm such advice in writing, as soon as reasonably practicable
after notice thereof is received by the Issuer (A) when the applicable
Registration Statement or any amendment thereto has been filed or becomes
effective and when the applicable Prospectus or any Issuer Free Writing
Prospectus or any amendment or supplement thereto has been filed, (B) of
any written comments by the SEC or any request by the SEC or any other federal
or state governmental authority for amendments or supplements to any such
Registration Statement, Prospectus or Free Writing Prospectus or for additional
information, (C) of the issuance by the SEC of any stop order suspending
the effectiveness of such Registration Statement or any order or notice
preventing or suspending the use of any preliminary or final Prospectus or any
Issuer Free Writing Prospectus or the initiation or threat of any proceedings
for such purposes and (D) of the receipt by the Issuer of any notification
with respect to the suspension of the qualification of the Registrable
Securities for offering or sale in any jurisdiction or the initiation or threat
of any proceeding for such purpose;

 

(iv)                              promptly notify each selling holder of
Registrable Securities and the managing underwriter or underwriters, if any,
when the Issuer becomes aware of the happening of any event as a result of
which the applicable Registration Statement, Prospectus (as then in effect) or
any Issuer Free Writing Prospectus contains any untrue statement of a material
fact or omits to state a material fact necessary to make the statements therein
(in the case of a Prospectus or Issuer Free Writing Prospectus, in the light of
the circumstances under which they were made) not misleading, when any Issuer
Free Writing Prospectus includes information that may conflict with the
information contained in the Registration Statement, or, if for any other
reason it shall be necessary to amend or supplement any such Registration
Statement, Prospectus or Issuer Free Writing Prospectus in order to comply with
the Securities Act and, in either case, subject to Sections 2.1(c) and
2.2(e), as promptly as reasonably practicable thereafter, prepare and file with
the SEC an amendment or supplement to such Registration Statement, Prospectus 

 

 

 

 

12

 

 

or Free Writing Prospectus which will correct such
statement or omission or effect such compliance;

 

(v)                                 make every reasonable effort to prevent
or obtain at the earliest possible moment the withdrawal of any stop order with
respect to the applicable Registration Statement or other order or notice
preventing or suspending the use of any preliminary or final Prospectus or any
Issuer Free Writing Prospectus;

 

(vi)                              promptly incorporate in a Prospectus
supplement, Issuer Free Writing Prospectus or post-effective amendment to the
applicable Registration Statement such information as the managing underwriter
or underwriters, if any, or the holders of a majority of the Registrable
Securities of the class being sold agree should be included therein relating to
the plan of distribution with respect to such Registrable Securities, and make,
subject to Sections 2.1(c) and 2.2(e), all required filings of such
Prospectus supplement, Issuer Free Writing Prospectus or post-effective
amendment as soon as reasonably practicable after being notified of the matters
to be incorporated in such Prospectus supplement, Issuer Free Writing
Prospectus or post-effective amendment;

 

(vii)                           furnish to each selling holder of
Registrable Securities and each managing underwriter, if any, without charge,
as many conformed copies as such holder or managing underwriter may reasonably
request of the applicable Registration Statement;

 

(vii)                           deliver to each selling holder of
Registrable Securities and each managing underwriter, if any, without charge,
as many copies of the applicable Prospectus (including each preliminary
Prospectus) and any Issuer Free Writing Prospectus as such holder or managing
underwriter may reasonably request (it being understood that the Issuer
consents to the use of the Prospectus and any Issuer Free Writing Prospectus by
each of the selling holders of Registrable Securities and the underwriter or
underwriters, if any, in connection with the offering and sale of the
Registrable Securities covered thereby) and such other documents as such
selling holder or managing underwriter may reasonably request in order to
facilitate the disposition of the Registrable Securities by such holder or underwriter;

 

(ix)                                on or prior to the date on which the
applicable Registration Statement becomes effective, use its reasonable best
efforts to register or qualify such Registrable Securities for offer and sale
under the securities or “Blue Sky” laws of each state and other jurisdiction of
the United States, as any such selling holder or underwriter, if any, or their
respective counsel reasonably requests in writing, and do any and all other
acts or things reasonably necessary or advisable to keep such registration or
qualification in effect so as to permit the commencement and continuance of
sales and dealings in such jurisdictions for as long as may be necessary to
complete the distribution of the Registrable Securities covered by the
Registration Statement; provided, however, that the Issuer will
not be required to qualify generally to do business in any jurisdiction where
it is not then so qualified or to take any action which would subject it to
taxation or general service of process in any such jurisdiction where it is not
then so subject;

 

(x)                                   cooperate with the selling holders of
Registrable Securities and the managing underwriter, underwriters or agent, if
any, to facilitate the timely preparation and 

 

 

 

 

13

 

 

delivery of certificates representing Registrable
Securities to be sold and not bearing any restrictive legends;

 

(xi)                                use its reasonable best efforts to cause
the Registrable Securities covered by the applicable Registration Statement to
be registered with or approved by such other governmental agencies or
authorities as may be necessary to enable the seller or sellers thereof or the
underwriter or underwriters, if any, to consummate the disposition of such
Registrable Securities;

 

(xii)                             not later than the effective date of the
applicable Registration Statement, provide a CUSIP number for all Registrable
Securities and provide the applicable transfer agent with printed certificates
for the Registrable Securities which certificates shall be in a form eligible
for deposit with The Depository Trust Company;

 

(xiii)                          obtain for delivery to the holders of
each class of Registrable Securities being registered and to the underwriter or
underwriters, if any, an opinion or opinions from counsel for the Issuer dated
the effective date of the Registration Statement or, in the event of an
Underwritten Offering, the date of the closing under the underwriting
agreement, in customary form, scope and substance, which counsel and opinions
shall be reasonably satisfactory to a majority of the holders of each such
class and underwriter or underwriters, if any, and their respective counsel;

 

(xiv)                         in the case of an Underwritten Offering,
obtain for delivery to the Issuer and the underwriter or underwriters, if any,
with copies to the holders of Registrable Securities included in such
registration, cold comfort letters from the Issuer’s independent certified
public accountants in customary form and covering such matters of the type
customarily covered by cold comfort letters as the managing underwriter or
underwriters reasonably request;

 

(xv)                            cooperate with each seller of Registrable
Securities and each underwriter or agent, if any, participating in the
disposition of such Registrable Securities and their respective counsel in
connection with any filings required to be made with FINRA;

 

(xvi)                         use its reasonable best efforts to comply
with all applicable rules and regulations of the SEC and make generally
available to its security holders, as soon as reasonably practicable (but not
more than 15 months) after the effective date of the applicable Registration
Statement, an earnings statement satisfying the provisions of Section 11(a) of
the Securities Act and the rules and regulations promulgated thereunder;

 

(xvii)                      provide and cause to be maintained a
transfer agent and registrar for all Registrable Securities covered by the
applicable Registration Statement from and after a date not later than the
effective date of such Registration Statement;

 

(xviii)                   cause all Registrable Securities of a
class covered by the applicable Registration Statement to be listed or quoted
on each securities exchange on which any of the Issuer’s securities of such
class are then listed or quoted and on each inter-dealer quotation system on
which any of the Issuer’s securities of such class are then quoted;

 

 

 

 

14

 

 

(xix)                           make available upon reasonable notice at
reasonable times and for reasonable periods for inspection by a representative
appointed by the holders of a majority of the Registrable Securities of each
class covered by the applicable Registration Statement, by any managing
underwriter or underwriters participating in any disposition to be effected
pursuant to such Registration Statement and by any attorney, accountant or
other agent retained by such sellers or any such managing underwriter (each an “Inspector”,
and collectively, the “Inspectors”), all pertinent financial and other
records, pertinent corporate documents and properties of the Issuer (collectively,
the “Records”), and cause all of the Issuer’s officers, directors and
employees and the independent public accountants who have certified its
financial statements to make themselves reasonably available to discuss the
business of the Issuer and to supply all information reasonably requested by
the Inspectors in connection with such Registration Statement as shall be
necessary to enable them to exercise their due diligence responsibility; provided
that Records that the Issuer determines, in good faith, to be confidential and
which it notifies the Inspectors are confidential shall not be disclosed by the
Inspectors (and the Inspectors shall confirm their agreement in writing in
advance to the Issuer if the Issuer shall so request) unless (a) the
disclosure of such Records is necessary, in the Issuer’s judgment, to avoid or
correct a misstatement or omission in the Registration Statement, (b) the
release of such Records is ordered pursuant to a subpoena or other order from a
court of competent jurisdiction after exhaustion of all appeals therefrom or (c) the
information in such Records was known to the Inspectors on a non-confidential
basis prior to its disclosure by the Issuer or has been made generally
available to the public.  Each seller of
Registrable Securities agrees that it shall, upon learning that disclosure of
such Records is sought in a court of competent jurisdiction, give notice to the
Issuer and allow the Issuer, at the Issuer’s expense, to undertake appropriate
action to prevent disclosure of the Records deemed confidential.  In the event that the Issuer is unsuccessful
in preventing the disclosure of such Records, such seller agrees that it shall
furnish only that portion of those Records which it is advised by counsel is
legally required and shall exercise all reasonable efforts to obtain reliable
assurance that confidential treatment will be accorded to those Records;

 

(xx)                              in the case of an Underwritten Offering,
cause the senior executive officers of the Issuer to participate in the
customary “road show” presentations that may be reasonably requested by the
managing underwriter in any such Underwritten Offering and otherwise to
facilitate, cooperate with, and participate in, each proposed offering
contemplated herein and customary selling efforts related thereto; and

 

(xxi)                           promptly after the issuance of an
earnings release or upon the request of any holder, prepare a current report on
Form 8-K with respect to such earnings release or a matter of disclosure
as requested by such holder and file such Form 8-K with the SEC.

 

(b)                                 The Issuer may require each selling
holder of Registrable Securities as to which any registration is being effected
to furnish to the Issuer such information regarding the distribution of such
Securities and such other information relating to such holder and its ownership
of the applicable Registrable Securities as the Issuer may from time to time
reasonably request.  Each holder of
Registrable Securities agrees to furnish such information to the Issuer and to
cooperate with the Issuer as necessary to enable the Issuer to comply with the
provisions of this Agreement.  The Issuer
shall have the right to exclude any holder that does not comply with the
preceding sentence from the applicable registration.

 

 

 

 

 

15

 

 

(c)                                  Each holder of Registrable Securities
agrees by acquisition of such Registrable Securities that, upon receipt of any
notice from the Issuer of the happening of any event of the kind described in Section 2.5(a)(iv),
such holder will discontinue disposition of its Registrable Securities pursuant
to such Registration Statement until such holder’s receipt of the copies of the
supplemented or amended Prospectus or Issuer Free Writing Prospectus, as the
case may be, contemplated by Section 2.5(a)(iv), or until such holder is
advised in writing by the Issuer that the use of the Prospectus or Issuer Free
Writing Prospectus, as the case may be, may be resumed, and has received copies
of any additional or supplemental filings that are incorporated by reference in
the Prospectus or such Issuer Free Writing Prospectus or any amendments or
supplements thereto and, if so directed by the Issuer, such holder will deliver
to the Issuer (at the Issuer’s expense) all copies, other than permanent file
copies then in such holder’s possession, of the Prospectus or any Issuer Free
Writing Prospectus covering such Registrable Securities which are current at
the time of the receipt of such notice. 
In the event that the Issuer shall give any such notice in respect of a
Demand Registration, the period during which the applicable Registration
Statement is required to be maintained effective shall be extended by the
number of days during the period from and including the date of the giving of
such notice to and including the date when each seller of Registrable
Securities covered by such Registration Statement either receives the copies of
the supplemented or amended Prospectus or Issuer Free Writing Prospectus
contemplated by Section 2.5(a)(iv) or is advised in writing by the
Issuer that the use of the Prospectus or Issuer Free Writing Prospectus may be
resumed.

 

(d)                                 Each holder of Registrable Securities
agrees by acquisition of such Registrable Securities that it will not use any
Free Writing Prospectus relating to the offer or sale of such securities
without the prior written consent of the Issuer, which shall not be
unreasonably withheld or delayed.

 

2.6.                              Underwritten Offerings.

 

(a)                                  Underwriting Agreements. 
If requested by the underwriters for any Underwritten Offering requested
by holders pursuant to Section 2.1 or 2.2, the Issuer and the holders of
Registrable Securities to be included therein shall enter into an underwriting
agreement with such underwriters, such agreement to be reasonably satisfactory
in substance and form to the Issuer, the holders of a majority of each class of
the Registrable Securities to be included in such Underwritten Offering and the
underwriters, and to contain such terms and conditions as are generally prevailing
in agreements of that type, including, without limitation, indemnities no less
favorable to the recipient thereof than those provided in Section 2.9.  The holders of any Registrable Securities to
be included in any Underwritten Offering pursuant to Section 2.3 shall
enter into such an underwriting agreement at the request of the Issuer.  All of the representations and warranties by,
and the other agreements on the part of, the Issuer to and for the benefit of
such underwriters included in each such underwriting agreement shall also be
made to and for the benefit of such holders and any or all of the conditions
precedent to the obligations of such underwriters under such underwriting
agreement be conditions precedent to the obligations of such holders.  No holder shall be required in any such
underwriting agreement to make any representations or warranties to, or
agreements with, the Issuer or the underwriters other than representations,
warranties or agreements regarding such holder, such holder’s Registrable
Securities, such holder’s intended method of distribution and any other
representations required by law.

 

 

 

 

16

 

 

(b)                                 Price and Underwriting Discounts. 
In the case of an Underwritten Offering requested by holders pursuant to
Section 2.1 or 2.2, the price, underwriting discount and other financial
terms for each class of Registrable Securities of the related underwriting
agreement shall be determined by the holders of a majority of such class of
Registrable Securities included in such Underwritten Offering.  In the case of any Underwritten Offering
pursuant to Section 2.3, such price, discount and other terms shall be
determined by the Issuer, subject to the right of the holders to withdraw their
request to participate in the registration pursuant to Section 2.3(a)(iii) after
being advised of such price, discount and other terms.

 

(c)                                  Participation in Underwritten Offerings. 
No Person may participate in an Underwritten Offering unless such Person
(i) agrees to sell such Person’s securities on the basis provided in any
underwriting arrangements approved by the Persons entitled to approve such
arrangements and (ii) completes and executes all questionnaires, powers of
attorney, indemnities, underwriting agreements and other documents required
under the terms of such underwriting arrangements.

 

2.7.                              No Inconsistent Agreements; Additional
Rights.  The Issuer will not enter into, and is not
currently a party to, any agreement which is, or could be, inconsistent with
the rights granted to the holders of Registrable Securities by this Agreement.

 

2.8.                              Registration Expenses.  (a) 
Subject to Section 2.2(c), the Issuer shall pay all of the expenses set
forth in this Section 2.8(a) in connection with its performance or
compliance with this Agreement, including (i) all registration and filing
fees, and any other fees and expenses associated with filings required to be
made with the SEC or FINRA, (ii) all fees and expenses of compliance with
state securities or “Blue Sky” laws, (iii) all printing, duplicating, word
processing, messenger, telephone, facsimile and delivery expenses (including
expenses of printing certificates for the Registrable Securities in a form
eligible for deposit with The Depository Trust Company and of printing
prospectuses and Issuer Free Writing Prospectuses), (iv) all fees and
disbursements of counsel for the Issuer and of all independent certified public
accountants of the Issuer, (v) Securities Act liability insurance or
similar insurance if the Issuer so desires or the underwriter or underwriters,
if any, so require in accordance with then-customary underwriting practice, (vi) all
fees and expenses incurred in connection with the listing of the Registrable
Securities on any securities exchange or the quotation of the Registrable
Securities on any inter-dealer quotation system and (vii) all applicable
rating agency fees with respect to any applicable Registrable Securities.  In addition, in all cases the Issuer shall
pay its internal expenses (including, without limitation, all salaries and
expenses of its officers and employees performing legal or accounting duties),
the expense of any audit and the fees and expenses of any Person, including
special experts, retained by the Issuer.  In addition, the Issuer shall pay all
reasonable fees and disbursements of one law firm or other counsel selected by
the holders of a majority of the Registrable Securities being registered.

 

(b)                                 The Issuer shall not be required to pay
any other costs or expenses in the course of the transactions contemplated
hereby, including underwriting discounts and commissions and transfer taxes
attributable to the sale of Registrable Securities and the fees and expenses of
counsel to the underwriters other than pursuant to Section 2.8(a).

 

 

 

 

17

 

 

2.9.                              Indemnification.

 

(a)                                  Indemnification by the Issuer. 
The Issuer agrees to indemnify and hold harmless, to the full extent
permitted by law, each holder of Registrable Securities and their respective
affiliates, and each of their respective officers, directors, partners, members, employees, agents,
counsel, financial advisors and assignees (including affiliates of such
assignees) and each Person who controls (within the meaning of the Securities
Act or the Exchange Act) such Persons from and against any and all losses,
claims, damages, liabilities (or actions or proceedings in respect thereof,
whether or not such indemnified party is a party thereto) and expenses
(including reasonable costs of investigation and reasonable legal expenses),
joint or several (each, a “Loss” and collectively “Losses”),
arising out of or based upon (i) any untrue or alleged untrue statement of
a material fact contained in any Registration Statement under which such
Registrable Securities were registered under the Securities Act (including any
final, preliminary or summary Prospectus contained therein or any amendment
thereof or supplement thereto or any documents incorporated by reference
therein) or any Issuer Free Writing Prospectus or amendment thereof or
supplement thereto or (ii) any omission or alleged omission to state
therein a material fact required to be stated therein or necessary to make the
statements therein (in the case of a Prospectus or Issuer Free Writing
Prospectus, in the light of the circumstances under which they were made) not
misleading, and the Issuer agrees to reimburse (on an as-incurred monthly
basis) each indemnified party for any reasonable legal or other reasonable
expenses incurred in connection with investigating, defending or participating
in any such Loss (whether or not such indemnified party is a party to any
action or proceeding out of which indemnified expenses arise); provided,
however, that the Issuer shall not be liable to any indemnified party in
any such case to the extent that any such Loss arises out of or is based upon
an untrue statement or alleged untrue statement or omission or alleged omission
made in any such Registration Statement in reliance upon and in conformity with
written information furnished to the Issuer by such holder expressly for use in
the preparation thereof.  This indemnity
shall be in addition to any liability the Issuer may otherwise have.  Such indemnity shall remain in full force and
effect regardless of any investigation made by or on behalf of such holder or
any indemnified party and shall survive the transfer of such securities by such
holder.  The Issuer will also indemnify,
if applicable and if requested, underwriters, selling brokers, dealer managers
and similar securities industry professionals participating in any distribution
pursuant hereto, their officers and directors and each Person who controls such
Persons (within the meaning of the Securities Act and the Exchange Act) to the
same extent as provided above with respect to the indemnification of the
Indemnified Persons.

 

(b)                                 Indemnification by the Holders. 
Each selling holder of Registrable Securities agrees (severally and not
jointly) to indemnify and hold harmless, to the full extent permitted by law,
the Issuer, its officers, directors, employees, agents, counsel and financial
advisors and each Person who controls the Issuer (within the meaning of the
Securities Act and the Exchange Act) from and against any Losses resulting from
any untrue statement of a material fact or any omission of a material fact
required to be stated in the Registration Statement under which such
Registrable Securities were registered under the Securities Act (including any
final, preliminary or summary Prospectus contained therein or any amendment
thereof or supplement thereto or any documents incorporated by reference
therein) or any Issuer Free Writing Prospectus or amendment thereof or
supplement thereto, or necessary to make the statements therein (in the case of
a Prospectus or Issuer Free Writing Prospectus, in the light of the

 

 

 

 

 

 

18

 

 

circumstances under which they were made) not
misleading, to the extent, but only to the extent, that such untrue statement
or omission had been contained in any information furnished in writing by such
selling holder to the Issuer specifically for inclusion in such Registration
Statement, including, without limitation, information furnished to the Issuer
pursuant to Section 2.5(b) hereof. 
This indemnity shall be in addition to any liability such holder may
otherwise have.  In no event shall the
liability of any selling holder of Registrable Securities hereunder be greater
in amount than the dollar amount of the proceeds received by such holder under
the sale of the Registrable Securities giving rise to such indemnification
obligation.

 

(c)                                  Conduct of Indemnification Proceedings. 
Any Person entitled to indemnification hereunder will (i) give
prompt written notice to the indemnifying party of any claim with respect to
which it seeks indemnification (provided,
however,  that any delay or
failure to so notify the indemnifying party shall relieve the indemnifying
party of its obligations hereunder only to the extent, if at all, that it is
actually and materially prejudiced by reason of such delay or failure)
and (ii) permit such indemnifying party to assume the defense of such
claim with counsel chosen by it and reasonably satisfactory to the indemnified
party; provided, however, that any Person entitled to
indemnification hereunder shall have the right to select and employ separate
counsel and to participate in the defense of such claim, but the fees and
expenses of such counsel shall be at the expense of such Person unless (A) the
indemnifying party has agreed in writing to pay such fees or expenses, (B) the
indemnifying party shall have failed to assume the defense of such claim within
a reasonable time after having received notice of such claim from the Person
entitled to indemnification hereunder and to employ counsel reasonably
satisfactory to such Person, (C) in
the reasonable judgment of any such Person, based upon advice of its counsel, a
conflict of interest may exist between such Person and the indemnifying party
with respect to such claims or (D) the
indemnified party has reasonably concluded (based on advice of counsel) that
there may be legal defenses available to it or other indemnified parties that
are different from, or in addition to, those available to the indemnifying
party (in which case, if the Person notifies the indemnifying party in
writing that such Person elects to employ separate counsel at the expense of
the indemnifying party, the indemnifying party shall not have the right to
assume the defense of such claim on behalf of such Person).  If such defense is not assumed by the
indemnifying party, the indemnifying party will not be subject to any liability
for any settlement made without its consent, but such consent may not be
unreasonably withheld; provided, however, that an indemnifying
party shall not be required to consent to any settlement involving the
imposition of equitable remedies or involving the imposition of any material
obligations on such indemnifying party other than financial obligations for
which such indemnified party will be indemnified hereunder.  If the indemnifying party assumes the
defense, the indemnifying party shall have the right to settle such action
without the consent of the indemnified party; provided, however,
that the indemnifying party shall be required to obtain such consent (which
consent shall not be unreasonably withheld) if the settlement includes any admission
of wrongdoing on the part of the indemnified party or any restriction on the
indemnified party or its officers or directors. 
No indemnifying party shall consent to entry of any judgment or enter
into any settlement which does not include as an unconditional term thereof the
giving by the claimant or plaintiff to each indemnified party of an
unconditional release from all liability in respect to such claim or
litigation.  The indemnifying party or
parties shall not, in connection with any proceeding or related proceedings in the same jurisdiction, be liable
for the reasonable fees, disbursements and other charges of more than one
separate firm (together with one firm
of local counsel) at any one time from all such indemnified 

 

 

 

 

19

 

 

party or parties unless (x) the employment of
more than one counsel has been authorized in writing by the indemnifying party
or parties, (y) a conflict or potential conflict exists or may exist
(based on advice of counsel to an indemnified party) between such indemnified
party and the other indemnified parties or
(z) an indemnified party has reasonably concluded (based on advice of
counsel) that there may be legal defenses available to it that are different
from, or in addition to, those available to the other indemnified parties, in
each of which cases the indemnifying party shall be obligated to pay the
reasonable fees and expenses of such additional counsel or counsels.

 

(d)                                 Contribution. 
If for any reason the indemnification provided for in paragraphs (a) and
(b) of this Section 2.9 is unavailable to an indemnified party or
insufficient to hold it harmless as contemplated by paragraphs (a) and (b) of
this Section 2.9, then the indemnifying party shall contribute to the
amount paid or payable by the indemnified party as a result of such Loss in
such proportion as is appropriate to reflect the relative fault of the
indemnifying party on the one hand and the indemnified party on the other.  The relative fault shall be determined by
reference to, among other things, whether the untrue or alleged untrue
statement of a material fact or the omission or alleged omission to state a
material fact relates to information supplied by the indemnifying party or the
indemnified party and the parties’ relative intent, knowledge, access to
information and opportunity to correct or prevent such untrue statement or
omission.  Notwithstanding anything in
this Section 2.9(d) to the contrary, no indemnifying party (other
than the Issuer) shall be required pursuant to this Section 2.9(d) to
contribute any amount in excess of the amount by which the net proceeds
received by such indemnifying party from the sale of Registrable Securities in
the offering to which the Losses of the indemnified parties relate exceeds the
amount of any damages which such indemnifying party has otherwise been required
to pay by reason of such untrue statement or omission.  The parties hereto agree that it would not be
just and equitable if contribution pursuant to this Section 2.9(d) were
determined by pro  rata allocation or by any other method of
allocation that does not take account of the equitable considerations referred
to in the immediately preceding paragraph. 
No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of
the Securities Act) shall be entitled to contribution from any Person who was
not guilty of such fraudulent misrepresentation.  If indemnification is available
under this Section 2.9, the indemnifying parties shall indemnify each
indemnified party to the full extent provided in Sections 2.9(a) and 2.9(b) hereof
without regard to the relative fault of said indemnifying parties or
indemnified party.

 

2.10.                        Rules 144 and 144A. 
The Issuer covenants that it will take such action to the extent
required from time to time to enable any holder of Registrable Securities to
sell Registrable Securities without registration under the Securities Act
within the limitation of the exemptions provided by (i) Rule 144 or
144A or Regulation S under the Securities Act, as such Rules may be
amended from time to time, or (ii) any similar rule or regulation
hereafter adopted by the SEC.  Upon the request of any holder of
Registrable Securities, the Issuer will deliver to such holder a written statement
as to whether it has complied with such requirements and, if not, the specifics
thereof.

 

 

 

 

20

 

 

SECTION 3.   MISCELLANEOUS

 

3.1.                              Existing Registration Statements. 
Notwithstanding anything herein to the contrary and subject to
applicable law and regulation, the Issuer may satisfy any obligation hereunder
to file a Registration Statement or to have a Registration Statement become
effective by a specified date by designating, by notice to the Significant
Equityholders, a registration statement that previously has been filed with the
SEC or become effective, as the case may be, as the relevant Registration
Statement for purposes of satisfying such obligation, and all references to any
such obligation shall be construed accordingly. 
To the extent this Agreement refers to the filing or effectiveness of
other registration statements by or at a specified time and the Issuer has, in
lieu of then filing such registration statements or having such registration
statements become effective, designated a previously filed or effective
registration statement as the relevant registration statement for such
purposes, such references shall be construed to refer to such designated
registration statement.

 

3.2.                              Term.  This
Agreement shall terminate upon the earliest of (i) the later of (A) the
two-year anniversary of the date of this Agreement and (B) the two-year
anniversary of the initial Shelf Registration, if any, becoming effective and (ii) the
date as of which (A) all of the Registrable Securities have been sold
pursuant to a Registration Statement (but in no event prior to the applicable
period referred to in Section 4(3) of the Securities Act and Rule 174
thereunder), (B) the holders are permitted to sell their Registrable
Securities under Rule 144 under the Securities Act without limitation on
volume or the manner of sale (or any similar provision then in force permitting
the sale of restricted securities without limitation on the amount of
securities sold or the manner of sale) or (C) all Registrable Securities
having ceased to be Registrable Securities pursuant to the definition
thereof.  The provisions of Section 2.9
and Section 2.10 shall survive any termination of this Agreement.

 

3.3.                              Injunctive
Relief.  It is hereby agreed and
acknowledged that it will be impossible to measure in money the damages that
would be suffered if the parties fail to comply with any of the obligations
herein imposed on them and that in the event of any such failure, an aggrieved
Person will be irreparably damaged and will not have an adequate remedy at
law.  Any such Person shall, therefore,
be entitled (in addition to any other remedy to which it may be entitled in law
or in equity) to injunctive relief, including, without limitation, specific
performance, to enforce such obligations, and if any action should be brought
in equity to enforce any of the provisions of this Agreement, none of the
parties hereto shall raise the defense that there is an adequate remedy at law.

 

3.4.                              Attorneys’
Fees.  In any action or proceeding
brought to enforce any provision of this Agreement or where any provision
hereof is validly asserted as a defense, the successful party shall, to the
extent permitted by applicable law, be entitled to recover reasonable attorneys’
fees in addition to any other available remedy.

 

3.5.                              Notices.  (a) All
notices, other communications or documents provided for or permitted to be
given hereunder, shall be made in writing and shall be given either personally
by hand delivery, by facsimile transmission, by electronic mail, by mailing the
same in a sealed envelope, registered or certified first-class mail, postage
prepaid, return receipt requested, or by air courier guaranteeing overnight
delivery:

 

 

 

 

 

21

 

 

If to the Significant Equityholders, to:
 

D. E. Shaw Laminar Portfolios, L.L.C.

c/o D. E. Shaw & Co., L.P.

120 West 45th Street, 39th Floor

New York, New York 10036

Attention: Maureen Knoblauch

Telephone No.: 
(212) 478-0628

Facsimile No.: 
(212) 845-1628

E-mail: Maureen.Knoblauch@deshaw.com

 

Sigma Capital Associates, LLC

540 Madison Avenue

New York, New York 10022

Attention:  Peter Nussbaum

Telephone No.: 
(203) 614-2094

Facsimile No.: 
(203) 614-2393

E-mail: 
petern@saccapital.com

 

With a copy to:

John Reilly

Telephone No.:  (212) 756-1568

Facsimile No.:  (203) 890-6678

E-mail:  johnre@sigmacapny.com

 

CGDO, LLC (as agent on behalf of Chilton Global
Distressed Opportunities Master Fund, L.P.) and Q Funding III, L.P.

  c/o Chilton
Capital Management, LLC

1266 East Main Street, 7th Floor

Stamford, Connecticut 06902

Attention: 
Montes Piard

Telephone No.:  
(203) 352-4077

Facsimile No.: 
(203) 352-4078

E-mail: mpiard@chiltoninc.com

 

With a copy to:

 

Cleary Gottlieb Steen & Hamilton LLP

One Liberty Plaza

New York, NY 10006

Attention: 
Richard J. Cooper, Esq.

Telephone No.: 
(212) 225-2000

Facsimile No.: 
(212) 225-3999

E-mail: 
rcooper@cgsh.com

 

 

 

 

 

22

 

 

If to the Issuer, to:

 

Foamex International Inc.

1000 Columbia Avenue

Linwood, PA 19061

Attention: 
Andrew R. Prusky, Esq.

Senior Vice President, Legal

Telephone No.: 
(610) 859-3000

Facsimile No.:  
(610) 859-3024

E-mail: 
aprusky@foamex.com

 

With a copy to:

 

Paul, Weiss, Rifkind, Wharton & Garrison LLP

1285 Avenue of the Americas

New York, NY 
10019

Attention: 
Judith R. Thoyer, Esq.

Telephone No.: 
(212) 373-3002

Facsimile No.: 
(212) 492-0002

E-mail: 
jthoyer@paulweiss.com

 

(b)                                 Each holder, by written notice given to
the Issuer in accordance with this Section 3.5 may change the address to
which notices, other communications or documents are to be sent to such
holder.  All notices, other
communications or documents shall be deemed to have been duly given:  (i) at the time delivered by hand, if
personally delivered; (ii) when receipt is acknowledged in writing by
addressee, if by facsimile transmission; (iii) five business days after
having been deposited in the mail, postage prepaid, if mailed by first class
mail; (iv) when receipt is acknowledged, if transmitted by facsimile
transmission or by electronic mail; and (v) on the first business day with
respect to which a reputable air courier guarantees delivery; provided,
however, that notices of a change of address shall be effective only upon
receipt.

 

3.6.                              Successors, Assigns and Transferees.  (a) 
The registration rights of any holder under this Agreement with respect to any
Registrable Securities may be transferred and assigned, provided, however,
that no such transfer or assignment shall be binding upon or obligate the
Issuer to any such assignee unless and until the Issuer shall have received
notice of such assignment as herein provided and a written agreement of the
assignee to be bound by the provisions of this Agreement.  Any transfer or assignment made other than as
provided in the first sentence of this Section 3.6 shall be null and void.

 

(b)                                 This Agreement shall be binding upon and
shall inure to the benefit of the parties hereto, and their respective
successors and permitted assigns.

 

3.7.                              Governing Law; Service of Process;
Consent to Jurisdiction.  (a)  This Agreement shall
be governed by and construed in accordance with the laws of the State of New
York applicable to agreements made and to be performed within the state.

 

 

 

 

 

23

 

 

(b)                                 To the fullest extent permitted by
applicable law, each party hereto (i) agrees that any claim, action or
proceeding by such party seeking any relief whatsoever arising out of, or in
connection with, this Agreement or the transactions contemplated hereby shall
be brought only in the United States District Court for the Southern District
of New York and in any New York State court located in the Borough of Manhattan
and not in any other State or Federal court in the United States of America or
any court in any other country, (ii) agrees to submit to the exclusive
jurisdiction of such courts located in the State of New York for purposes of
all legal proceedings arising out of, or in connection with, this Agreement or
the transactions contemplated hereby and (iii) irrevocably waives any
objection which it may now or hereafter have to the laying of the venue of any
such proceeding brought in such a court and any claim that any such proceeding
brought in such a court has been brought in an inconvenient forum.

 

(c)                                  The parties hereto hereby irrevocably
waive, to the fullest extent permitted by applicable law, any and all right to
trial by jury in any legal proceeding arising out of or relating to this
Agreement.

 

3.8.                              Headings.  The section
and paragraph headings contained in this Agreement are for reference purposes
only and shall not in any way affect the meaning or interpretation of this
Agreement.

 

3.9.                              Severability. 
Whenever possible, each provision or portion of any provision of this
Agreement will be interpreted in such manner as to be effective and valid under
applicable law but if any provision or portion of any provision of this
Agreement is held to be invalid, illegal or unenforceable in any respect under
any applicable law in any jurisdiction, such invalidity, illegality or
unenforceability will not affect any other provision or portion of any
provision in such jurisdiction, and this Agreement will be reformed, construed
and enforced in such jurisdiction as if such invalid, illegal or unenforceable
provision or portion of any provision had never been contained therein.

 

3.10.                        Amendment; Waiver.

 

(a)                                  This Agreement may not be amended or
modified and waivers and consents to departures from the provisions hereof may
not be given, except by an instrument or instruments in writing making specific
reference to this Agreement and signed by the Issuer and the holders of a
majority of Registrable Securities of each class then outstanding.  Each holder of any Registrable Securities at
the time or thereafter outstanding shall be bound by any amendment,
modification, waiver or consent authorized by this Section 3.10(a),
whether or not such Registrable Securities shall have been marked accordingly.

 

(b)                                 The waiver by any party hereto of a
breach of any provision of this Agreement shall not operate or be construed as
a further or continuing waiver of such breach or as a waiver of any other or
subsequent breach. Except as otherwise expressly provided herein, no failure on
the part of any party to exercise, and no delay in exercising, any right, power
or remedy hereunder, or otherwise available in respect hereof at law or in
equity, shall operate as a waiver thereof, nor shall any single or partial
exercise of such right, power or remedy by such party preclude any other or
further exercise thereof or the exercise of any other right, power or remedy.

 

 

 

24

 

 

 

3.11.                        Counterparts. 
This Agreement may be executed in any number of separate counterparts
and by the parties hereto in separate counterparts each of which when so
executed shall be deemed to be an original and all of which together shall
constitute one and the same agreement.

 

 

 

 

 

 

 

25

 

 

IN WITNESS WHEREOF, the parties hereto have caused this instrument to
be duly executed as of the date first written above.

 

	
  D. E. SHAW LAMINAR PORTFOLIOS, L.L.C.

  
	
   

  
	
   

  
	
  By:

  	
   

  	
   

  
	
   

  	
  Name:

  
	
   

  	
  Title:

  
	
   

  
	
   

  
	
  SIGMA CAPITAL ASSOCIATES, LLC

  
	
   

  
	
  By: Sigma Capital Management, LLC

  
	
   

  
	
   

  
	
  By:

  	
   

  	
   

  
	
   

  	
  Name:

  
	
   

  	
  Title:

  
	
   

  
	
   

  
	
  CGDO, LLC as agent on behalf of Chilton Global

  
	
  Distressed Opportunities Master Fund, LP

  
	
   

  
	
  By:

  	
  Chilton Investment Company, LLC

  
	
   

  	
  Managing Member

  
	
   

  
	
   

  
	
  By:

  	
   

  	
   

  
	
   

  	
  Name:

  
	
   

  	
  Title:

  
	
   

  
	
   

  
	
  Q FUNDING III, L.P.

  
	
   

  
	
  By:

  	
  Prufrock Onshore, L.P., its general partner

  
	
   

  
	
  By:

  	
  J Alfred Onshore, LLC, its general partner

  
	
   

  
	
  By:

  	
   

  	
   

  
	
   

  	
  Name:

  
	
   

  	
  Title:

  
	
   

  
	
   

  
	
  FOAMEX INTERNATIONAL INC.

  
	
   

  
	
   

  
	
  By:

  	
   

  	
   

  
	
   

  	
  Name:

  
	
   

  	
  Title:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00143-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00143-of-00352.parquet"}]]